<script lang="ts">
import { defineComponent } from 'vue'
// import type { DataTableColumns } from 'naive-ui'
// import Bi_table from '../components/Bi.vue'
// import Searchtable from '../components/Searchtable.vue'
// import Exceltable from '../components/Exceltable.vue'

// type DiType = {
//   no: number
//   depression_classification: string
//   diagnostic_criteria: string
//   depressive_symptom_degree: string
//   rating_scale: string
//   scale_scores_statistical_indicators: string
//   scale_scores_values: string
//   treatment: string
//   drug_name: string
//   comorbidity_mental_disease: string
//   underlying_diseases: string
//   pmid: string
// };

// const DiData = (): DiType[] => [
const DiData = [{"S-NO":1,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"13.17(3.425)(10-19)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":2,"Group name":"Major depressive disorders","Depressive disorders classification":"Major depressive disorder(single episode;recurrent episodes)","Diagnostic criteria":"ICD-10(F32.0;F33.0)","Depressive symptom degree":"Mild(15%);Moderate(40%);Severe(45%)","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"32.7(13.7)","Treatment protocol":"Medication","Drug name":"SSRI(41%);SNRI(32%);TCA(13.5%);Combined(13.5%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":3,"Group name":"Low-intensity and low-frequency","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Separation anxiety disorder;Generalized anxiety disorder;Panic disorder;Social anxiety disorder","Underlying diseases":"NA"},{"S-NO":3,"Group name":"Low-intensity and moderate-frequency","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Separation anxiety disorder;Generalized anxiety disorder;Panic disorder;Social anxiety disorder","Underlying diseases":"NA"},{"S-NO":3,"Group name":"Low-intensity and high-frequency","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Separation anxiety disorder;Generalized anxiety disorder;Panic disorder;Social anxiety disorder","Underlying diseases":"NA"},{"S-NO":3,"Group name":"High-intensity and low-frequency","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Separation anxiety disorder;Generalized anxiety disorder;Panic disorder;Social anxiety disorder","Underlying diseases":"NA"},{"S-NO":3,"Group name":"High-intensity and moderate-frequency","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Separation anxiety disorder;Generalized anxiety disorder;Panic disorder;Social anxiety disorder","Underlying diseases":"NA"},{"S-NO":3,"Group name":"High-intensity and high-frequency","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Separation anxiety disorder;Generalized anxiety disorder;Panic disorder;Social anxiety disorder","Underlying diseases":"NA"},{"S-NO":4,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.52(5.75)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"HIV(on HAART)"},{"S-NO":5,"Group name":"Physical exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"10.2(3.9)(3-16)","Treatment protocol":"Medication(55%)","Drug name":"Escitalopram;Fluoxetine;Mirtazapin;Duloxetin;Trazodone;Sertraline","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"NA"},{"S-NO":5,"Group name":"Physical exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"15.9(8.5)(3-32)","Treatment protocol":"Medication(55%)","Drug name":"Escitalopram;Fluoxetine;Mirtazapin;Duloxetin;Trazodone;Sertraline","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"NA"},{"S-NO":5,"Group name":"Physical exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"CDI","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"25.2(8.7)(12-44)","Treatment protocol":"Medication(55%)","Drug name":"Escitalopram;Fluoxetine;Mirtazapin;Duloxetin;Trazodone;Sertraline","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"NA"},{"S-NO":5,"Group name":"Physical exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"19.1(8.3(3-30)","Treatment protocol":"Medication(55%)","Drug name":"Escitalopram;Fluoxetine;Mirtazapin;Duloxetin;Trazodone;Sertraline","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"NA"},{"S-NO":5,"Group name":"Physical exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"0.73(0.14)(0.48-0.93)","Treatment protocol":"Medication(55%)","Drug name":"Escitalopram;Fluoxetine;Mirtazapin;Duloxetin;Trazodone;Sertraline","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"NA"},{"S-NO":6,"Group name":"HIIT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild;Moderate","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.9(5.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Coronary artery disease (CAD)"},{"S-NO":6,"Group name":"NW","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild;Moderate","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.5(6.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Coronary artery disease (CAD)"},{"S-NO":6,"Group name":"MICT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild;Moderate","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.9(7.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Coronary artery disease (CAD)"},{"S-NO":7,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Minimal(16.7%);Mild(41.7%);Moderate(29.2%);Severe(12.5%)","Rating scale":"BDI","Scale scores(statistical indicators)":"median(IQR)","Scale scores(values)":"15.5 (11.0-20.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer"},{"S-NO":8,"Group name":"MIAET","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35.4(4.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Obesity"},{"S-NO":8,"Group name":"MIAET+LFD","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"34.4(5.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Obesity"},{"S-NO":9,"Group name":"Taekwondo","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-K","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.64(1.75)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":9,"Group name":"Taekwondo","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-K,positive items","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.73(2.15)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":9,"Group name":"Taekwondo","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-K,negative","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.91(2.02)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":10,"Group name":"Intervention","Depressive disorders classification":"Prenatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"median(range)","Scale scores(values)":"17.58(16-19)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":11,"Group name":"Major depressive disorder","Depressive disorders classification":"Major depressive disorder\/Depression","Diagnostic criteria":"DSM-5\/ICD(F32-F34)","Depressive symptom degree":"NA","Rating scale":"QIDS-A17","Scale scores(statistical indicators)":"score(range)","Scale scores(values)":"14(6-18)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"ADHD;Anxiety disorders","Underlying diseases":"NA"},{"S-NO":12,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(range)","Scale scores(values)":"23.19(20-41)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":12,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.26(8.09)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":13,"Group name":"Supervised Aerobic Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"25th percentile\/Median\/75th percentile","Scale scores(values)":"14\/17\/20","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":13,"Group name":"Supervised Aerobic Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"25th percentile\/Median\/75th percentile","Scale scores(values)":"24\/31\/36","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":13,"Group name":"Home-Based Aerobic Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"25th percentile\/Median\/75th percentile","Scale scores(values)":"15\/17\/20 ","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":13,"Group name":"Home-Based Aerobic Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"25th percentile\/Median\/75th percentile","Scale scores(values)":"27\/30\/35","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":14,"Group name":"HIIT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-13","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5 (4.10)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":14,"Group name":"MIT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-13","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.23 (3.62)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":15,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5;K-SADS-PL","Depressive symptom degree":"Mild to moderate","Rating scale":"QIDS-A17 clinician","Scale scores(statistical indicators)":"median(95%Confidence Interval)","Scale scores(values)":"13.1(11.6-14.6)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"ADHD;Anxiety disorders","Underlying diseases":"NA"},{"S-NO":15,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5;K-SADS-PL","Depressive symptom degree":"Mild to moderate","Rating scale":"QIDS-A17 self report","Scale scores(statistical indicators)":"median(95%Confidence Interval)","Scale scores(values)":"15.7(13.4-17.9)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"ADHD;Anxiety disorders","Underlying diseases":"NA"},{"S-NO":16,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"NA"},{"S-NO":17,"Group name":"Exercise","Depressive disorders classification":"Unipolar depression(without psychotic episode)","Diagnostic criteria":"ICD-10(F32, F33)","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"median(Q1,Q3)","Scale scores(values)":"14.0(12.0,17.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":18,"Group name":"Exercise intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.7 (10.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Ovarian cancer(stage I-IV)"},{"S-NO":19,"Group name":"DEP(depression)","Depressive disorders classification":"Depressive disorder(major depressive episode and\/or persistent depressive disorder)","Diagnostic criteria":"DSM-5(SCID-5-RV)","Depressive symptom degree":"NA","Rating scale":"BDI-II,total","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.51(11.50)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Alcohol use disorder;Substance use disorder;Panic disorder;Agoraphobia;Social phobia;Post-Traumatic stress disorder;Binge eating disorder;Generalized anxiety disorder;Simple phobia;Somatic symptom disorder","Underlying diseases":"NA"},{"S-NO":19,"Group name":"DEP(depression)","Depressive disorders classification":"Depressive disorder(major depressive episode and\/or persistent depressive disorder)","Diagnostic criteria":"DSM-5(SCID-5-RV)","Depressive symptom degree":"NA","Rating scale":"BDI-II,cognitive","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.63(5.40)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Alcohol use disorder;Substance use disorder;Panic disorder;Agoraphobia;Social phobia;Post-Traumatic stress disorder;Binge eating disorder;Generalized anxiety disorder;Simple phobia;Somatic symptom disorder","Underlying diseases":"NA"},{"S-NO":19,"Group name":"DEP(depression)","Depressive disorders classification":"Depressive disorder(major depressive episode and\/or persistent depressive disorder)","Diagnostic criteria":"DSM-5(SCID-5-RV)","Depressive symptom degree":"NA","Rating scale":"BDI-II,somatic-affective","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.88(6.95)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Alcohol use disorder;Substance use disorder;Panic disorder;Agoraphobia;Social phobia;Post-Traumatic stress disorder;Binge eating disorder;Generalized anxiety disorder;Simple phobia;Somatic symptom disorder","Underlying diseases":"NA"},{"S-NO":21,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Minimal to severe","Rating scale":"BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":20,"Group name":"Training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"2.26(1.53)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":22,"Group name":"Total","Depressive disorders classification":"Post-stroke depression","Diagnostic criteria":"HAMD","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"score ","Scale scores(values)":"8.83(1.09)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Ischaemic stroke"},{"S-NO":23,"Group name":"Aerobic Exercise","Depressive disorders classification":"Depression(first episode, recurrent or bipolar)","Diagnostic criteria":"ICD-10(F32, F33, F31)","Depressive symptom degree":"Moderate to severe","Rating scale":"HDRS17","Scale scores(statistical indicators)":"mean (SD)","Scale scores(values)":"22.0(4.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Prior maniac episodes","Underlying diseases":"NA"},{"S-NO":23,"Group name":"Active Control","Depressive disorders classification":"Depression(first episode, recurrent or bipolar)","Diagnostic criteria":"ICD-10(F32, F33, F31)","Depressive symptom degree":"Moderate to severe","Rating scale":"HDRS17","Scale scores(statistical indicators)":"mean (SD)","Scale scores(values)":"20.9(2.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":24,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean (SD)","Scale scores(values)":"0.59(0.06)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":25,"Group name":"Physical Activity","Depressive disorders classification":"Depressive episode","Diagnostic criteria":"ICD-10","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean (SD)","Scale scores(values)":"15.1 (4.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":26,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"score ","Scale scores(values)":"\u226518","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":27,"Group name":"StD","Depressive disorders classification":"Subthreshold depression","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean (SD)","Scale scores(values)":"9.37 (2.75)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":28,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Borderline(33%)","Rating scale":"HADS","Scale scores(statistical indicators)":"score ","Scale scores(values)":"8-10","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms(Borderline anxiety;Severe anxiety;Covid-19 related dysfunctional anxiety)","Underlying diseases":"Covid-19"},{"S-NO":28,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Severe(9.2%)","Rating scale":"HADS","Scale scores(statistical indicators)":"score ","Scale scores(values)":"\u226511","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms(Borderline anxiety;Severe anxiety;Covid-19 related dysfunctional anxiety)","Underlying diseases":"Covid-19"},{"S-NO":29,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"SDS","Scale scores(statistical indicators)":"mean (SD)","Scale scores(values)":"57.85(5.19)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Gastrointestinal cancer"},{"S-NO":29,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"ATQ","Scale scores(statistical indicators)":"mean (SD)","Scale scores(values)":"48.33(8.13)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Gastrointestinal cancer"},{"S-NO":30,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"PHQ-8","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.7 (6.0) ","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic low back pain"},{"S-NO":30,"Group name":"Physical Therapy","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"PHQ-8","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.5 (6.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic low back pain"},{"S-NO":31,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"38.72(13.38)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":32,"Group name":"Group 1","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"median(min-max)","Scale scores(values)":"10.5 (1-22)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Chronic low back pain"},{"S-NO":32,"Group name":"Group 2","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"median(min-max)","Scale scores(values)":"9 (0-27)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Chronic low back pain"},{"S-NO":32,"Group name":"Group 3","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"median(min-max)","Scale scores(values)":"9.5 (2-38)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Chronic low back pain"},{"S-NO":33,"Group name":"Intervention","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"median (Q1, Q2)","Scale scores(values)":"14.0 (12.0, 17.0)","Treatment protocol":"Medication(41%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":34,"Group name":"Resistance-Trained","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"28.10(6.11)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":35,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"median (range)","Scale scores(values)":"7 (14)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":36,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.8 (9.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":38,"Group name":"MetS ","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.39(1.78)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":38,"Group name":"non-MetS","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.26(2.08)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":39,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Minimal to mild","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.43(2.04)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer(stage 0-3)"},{"S-NO":40,"Group name":"Resistance exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"5.93 (0.72)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":41,"Group name":"Total","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Postpartum anxiety","Underlying diseases":"NA"},{"S-NO":42,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to severe","Rating scale":"QIDS ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.67(2.83)","Treatment protocol":"Medication","Drug name":"SSRI;SNRI;Aminoketone;Tricyclic antidepressant;Tetracyclic antidepressant","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":43,"Group name":"Experimental Group1","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.50(4.93)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Self-perceived cognitive decline","Underlying diseases":"NA"},{"S-NO":44,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"HADS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Stroke"},{"S-NO":45,"Group name":"HIIT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.8 (6.23)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":45,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.4 (5.87)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":45,"Group name":"HIIT+yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.41 (5.43)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":46,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"DASS-21","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.37(1.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Hypothyroidism"},{"S-NO":47,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30.93(8.11)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":48,"Group name":"Yoga","Depressive disorders classification":"Major depression;Dysthymia;Bipolar disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.18 (5.55)","Treatment protocol":"Medication(90.3%)","Drug name":"SSRI;SNRI;Tricyclic antidepressant;Atypical antipsyhcotic;Mood stabilizer;Benzodiazepine;Other (stimulant, sleep aid)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":48,"Group name":"Yoga","Depressive disorders classification":"Major depression;Dysthymia;Bipolar disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.77 (7.28)","Treatment protocol":"Medication(90.3%)","Drug name":"SSRI;SNRI;Tricyclic antidepressant;Atypical antipsyhcotic;Mood stabilizer;Benzodiazepine;Other (stimulant, sleep aid)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":48,"Group name":"Yoga","Depressive disorders classification":"Major depression;Dysthymia;Bipolar disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"CGI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.64 (0.53)","Treatment protocol":"Medication(90.3%)","Drug name":"SSRI;SNRI;Tricyclic antidepressant;Atypical antipsyhcotic;Mood stabilizer;Benzodiazepine;Other (stimulant, sleep aid)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":48,"Group name":"Yoga","Depressive disorders classification":"Major depression;Dysthymia;Bipolar disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"25.59 (11.39)","Treatment protocol":"Medication(90.3%)","Drug name":"SSRI;SNRI;Tricyclic antidepressant;Atypical antipsyhcotic;Mood stabilizer;Benzodiazepine;Other (stimulant, sleep aid)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":49,"Group name":"Total","Depressive disorders classification":"Major depressive disorder;Persistent depressive disorder(dysthymia)","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.4(4.2)","Treatment protocol":"Medication","Drug name":"Imipramine","Comorbidity(mental disease)":"Social anxiety disorder;Obsessive-compulsive disorder;Gender identity disorder","Underlying diseases":"NA"},{"S-NO":49,"Group name":"Total","Depressive disorders classification":"Major depressive disorder;Persistent depressive disorder(dysthymia)","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"CGI-S","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.5(1.0)","Treatment protocol":"Medication","Drug name":"Imipramine","Comorbidity(mental disease)":"Social anxiety disorder;Obsessive-compulsive disorder;Gender identity disorder","Underlying diseases":"NA"},{"S-NO":49,"Group name":"Total","Depressive disorders classification":"Major depressive disorder;Persistent depressive disorder(dysthymia)","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"25.0(6.6)","Treatment protocol":"Medication","Drug name":"Imipramine","Comorbidity(mental disease)":"Social anxiety disorder;Obsessive-compulsive disorder;Gender identity disorder","Underlying diseases":"NA"},{"S-NO":50,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.2(1.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Breast cancer"},{"S-NO":51,"Group name":"Exercise compliant","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Minimal to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11(9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"HIV  "},{"S-NO":51,"Group name":"Non-compliant","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Minimal to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15(12)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"HIV  "},{"S-NO":52,"Group name":"Intervention","Depressive disorders classification":"Major depressive disorder(Recurrent;Dysthymia)","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.86 (5.83)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":53,"Group name":"Parkinson's disease","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES\u2010D","Scale scores(statistical indicators)":"mean[95%confidence interval]","Scale scores(values)":"17.3[12.9\u201321.6]","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Parkinson's disease"},{"S-NO":53,"Group name":"Healthy older adults","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES\u2010D","Scale scores(statistical indicators)":"mean[95%confidence interval]","Scale scores(values)":"15.0[11.7\u201318.3]","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":54,"Group name":"Running","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.2 (5.87)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":54,"Group name":"Stretching","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.8 (8.48)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":55,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"CES\u2010D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.3(11.4)","Treatment protocol":"Medication(54.55%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Stroke"},{"S-NO":55,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"Neuro-QOL depression SF","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.1(7.7)","Treatment protocol":"Medication(54.55%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Stroke"},{"S-NO":56,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":57,"Group name":"No abnormality,no intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"DASS-42","Scale scores(statistical indicators)":"mean","Scale scores(values)":"8.02","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms;Stress","Underlying diseases":"NA"},{"S-NO":57,"Group name":"No abnormality,intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"DASS-42","Scale scores(statistical indicators)":"mean","Scale scores(values)":"8.02","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms;Stress","Underlying diseases":"NA"},{"S-NO":57,"Group name":"Abnormality,no intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"DASS-42","Scale scores(statistical indicators)":"mean","Scale scores(values)":"12.05","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms;Stress","Underlying diseases":"NA"},{"S-NO":57,"Group name":"Abnormality,intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"DASS-42","Scale scores(statistical indicators)":"mean","Scale scores(values)":"11.42","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms;Stress","Underlying diseases":"NA"},{"S-NO":58,"Group name":"Exercise intervention(IG)","Depressive disorders classification":"Prenatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.2(5.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":59,"Group name":"Total","Depressive disorders classification":"Schizoaffective disorder depressed type","Diagnostic criteria":"DSM-IV(SCID-IV)","Depressive symptom degree":"NA","Rating scale":"BPRS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Schizophrenia, paranoid subtype;Schizophrenia catatonic subtype;Schizophrenia, undifferentiated subtype;Schizophreniform disorder","Underlying diseases":"NA"},{"S-NO":60,"Group name":"Yoga of Immortals(YOI) participants","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ-8","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.61(5.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":61,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to severe","Rating scale":"QIDS","Scale scores(statistical indicators)":"range","Scale scores(values)":"8-17","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":62,"Group name":"Yoga","Depressive disorders classification":"Unipolar depressive disorder(non-chronic)","Diagnostic criteria":"DSM-5","Depressive symptom degree":"Mild to moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.93(3.08)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"Social Phobia;Specific Phobia;Generalized Anxiety Disorder;Anxiety Disorder NOS","Underlying diseases":"NA"},{"S-NO":62,"Group name":"Exercise","Depressive disorders classification":"Unipolar depressive disorder(non-chronic)","Diagnostic criteria":"DSM-5","Depressive symptom degree":"Mild to moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.80(4.12)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"Panic Disorder;Social Phobia;Specific Phobia;Generalized Anxiety Disorder;Anxiety Disorder NOS;Obsessive Compulsive Disorder","Underlying diseases":"NA"},{"S-NO":63,"Group name":"Physical activity(PA)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"ICD-10(F32, F33)","Depressive symptom degree":"Mild to severe","Rating scale":"HAMD-17","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"19.17(0.78)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":63,"Group name":"Physical activity(PA)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"ICD-10(F32, F33)","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"27.74(1.44)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":64,"Group name":"Ergometer training","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV\/-5;ICD-10","Depressive symptom degree":"Moderate to severe","Rating scale":"DIKJ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.0(6.2)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"Anxiety;Somatoform disorders","Underlying diseases":"NA"},{"S-NO":64,"Group name":"WBV(whole body vibration device)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV\/-5;ICD-10","Depressive symptom degree":"Moderate to severe","Rating scale":"DIKJ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.9(6.2)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"Anxiety;Somatoform disorders","Underlying diseases":"NA"},{"S-NO":65,"Group name":"Ergometer training","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"DIKJ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.0(6.2)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"Anxiety;Somatoform disorders","Underlying diseases":"NA"},{"S-NO":65,"Group name":"Ergometer training","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"29.9(9.2)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"Anxiety;Somatoform disorders","Underlying diseases":"NA"},{"S-NO":65,"Group name":"WBV(whole body vibration device)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"DIKJ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.9(6.2)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"Anxiety;Somatoform disorders","Underlying diseases":"NA"},{"S-NO":65,"Group name":"WBV(whole body vibration device)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.7(13.1)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"Anxiety;Somatoform disorders","Underlying diseases":"NA"},{"S-NO":66,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.8(5.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Oncological disease"},{"S-NO":67,"Group name":"Proprioceptive exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"36.2(8.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Diabetic neuropathy"},{"S-NO":68,"Group name":"Depressive","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.3(2.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":69,"Group name":"RewP analyses;Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.06(8.03)","Treatment protocol":"Medication","Drug name":"Escitalopram;Sertraline","Comorbidity(mental disease)":"GAD;SAD;Panic disorder;PTSD","Underlying diseases":"NA"},{"S-NO":69,"Group name":"RewP analyses;Stretching","Depressive disorders classification":"Major depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.35(7.04)","Treatment protocol":"Medication","Drug name":"Escitalopram;Sertraline;Fluoxetine","Comorbidity(mental disease)":"GAD;OCD;Panic disorder;PTSD","Underlying diseases":"NA"},{"S-NO":69,"Group name":"ERN analyses;Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.81(7.93)","Treatment protocol":"Medication","Drug name":"Escitalopram;Sertraline","Comorbidity(mental disease)":"GAD;SAD;Panic disorder;PTSD","Underlying diseases":"NA"},{"S-NO":69,"Group name":"ERN analyses;Stretching","Depressive disorders classification":"Major depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.83(7.59)","Treatment protocol":"Medication","Drug name":"Escitalopram;Sertraline;Fluoxetine","Comorbidity(mental disease)":"GAD;OCD;Panic disorder;PTSD","Underlying diseases":"NA"},{"S-NO":70,"Group name":"Minimal","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Minimal","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.94(4.07)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":70,"Group name":"Mild","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.57(1.65)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":70,"Group name":"Moderate","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"BDI-II ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.47(2.43)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":71,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"ICD-10(F32.0-F33.9)","Depressive symptom degree":"Mild to severe","Rating scale":"DASS-21","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.19(10.60)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":71,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"ICD-10(F32.0-F33.9)","Depressive symptom degree":"Mild to severe","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"25.85(7.18)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":72,"Group name":"Efficacy Study;Standard multidomain","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS\u20105","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"0.4(0.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":72,"Group name":"Empowerment Study;Standard multidomain","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS\u20105","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"0.4(0.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":72,"Group name":"Empowerment Study;Enhanced multidomain","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS\u20105","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"0.4(0.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":73,"Group name":"Five-Animal Frolics Exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"CCMD-3","Depressive symptom degree":"NA","Rating scale":"HAMD ","Scale scores(statistical indicators)":"median(Q1,Q3)","Scale scores(values)":"12.0 (10.0, 14.0) ","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"Coronary heart disease (CHD)"},{"S-NO":73,"Group name":"Five-Animal Frolics Exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"CCMD-3","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"median(Q1,Q3)","Scale scores(values)":"41.0 (39.3, 47.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"Coronary heart disease (CHD)"},{"S-NO":75,"Group name":"Intervention","Depressive disorders classification":"Major depressive disorder(first episode, recurrent or bipolar)","Diagnostic criteria":"ICD-10(F32, F33, F31)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.6(10.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":75,"Group name":"Control","Depressive disorders classification":"Major depressive disorder(first episode, recurrent or bipolar)","Diagnostic criteria":"ICD-10(F32, F33, F31)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.9(6.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":76,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"HIV(on ART)"},{"S-NO":77,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"Severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"31.9(9.1)","Treatment protocol":"Medication;Counseling","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":78,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.3(3.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Metabolic syndrome"},{"S-NO":79,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CDS,Total depressive","Scale scores(statistical indicators)":"median(IQR)","Scale scores(values)":"42.00(36.50-46.00)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":79,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CDS,Total positives","Scale scores(statistical indicators)":"median(IQR)","Scale scores(values)":"147.00(123.75-176.00)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":80,"Group name":"Group A (Dietary+PA)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAD-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.9(3.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chinese colorectal cancer (CRC)"},{"S-NO":80,"Group name":"Group C (PA only)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAD-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.0(3.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chinese colorectal cancer (CRC)"},{"S-NO":81,"Group name":"Aerobic exercise","Depressive disorders classification":"Major depressive disorder(first episode, recurrent or bipolar)","Diagnostic criteria":"ICD-10(F32, F33, F31)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.4(9.1)","Treatment protocol":"Medication;Psychotherapy;Group therapies","Drug name":"SSRI;SNRI;Lithium;Quetiapine","Comorbidity(mental disease)":"Prior maniac episodes","Underlying diseases":"NA"},{"S-NO":81,"Group name":"Active control","Depressive disorders classification":"Major depressive disorder(first episode, recurrent or bipolar)","Diagnostic criteria":"ICD-10(F32, F33, F31)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"25.6(7.0)","Treatment protocol":"Medication;Psychotherapy;Group therapies","Drug name":"SSRI;SNRI;Lithium;Quetiapine","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":81,"Group name":"Aerobic exercise","Depressive disorders classification":"Major depressive disorder(first episode, recurrent or bipolar)","Diagnostic criteria":"ICD-10(F32, F33, F31)","Depressive symptom degree":"Moderate to severe","Rating scale":"HDRS17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.0(4.0)","Treatment protocol":"Medication;Psychotherapy;Group therapies","Drug name":"SSRI;SNRI;Lithium;Quetiapine","Comorbidity(mental disease)":"Prior maniac episodes","Underlying diseases":"NA"},{"S-NO":81,"Group name":"Active control","Depressive disorders classification":"Major depressive disorder(first episode, recurrent or bipolar)","Diagnostic criteria":"ICD-10(F32, F33, F31)","Depressive symptom degree":"Moderate to severe","Rating scale":"HDRS17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.9(2.6)","Treatment protocol":"Medication;Psychotherapy;Group therapies","Drug name":"SSRI;SNRI;Lithium;Quetiapine","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":82,"Group name":"Intervention","Depressive disorders classification":"Depression","Diagnostic criteria":"Standard semi-structured assessment interview undertaken face to face at the primary healthcare centre","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.43(4.11)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety","Underlying diseases":"NA"},{"S-NO":83,"Group name":"EP(Exercise programme)","Depressive disorders classification":"Acute depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.2 (5.0)","Treatment protocol":"Medication(47.8%);Psychotherapy(34.8%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":83,"Group name":"EP(Exercise programme)","Depressive disorders classification":"Acute depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.2 (9.1)","Treatment protocol":"Medication(47.8%);Psychotherapy(34.8%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":84,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.36 (2.62)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic physical illness"},{"S-NO":85,"Group name":"Tai chi","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS","Scale scores(statistical indicators)":"median (Q1, Q3)","Scale scores(values)":"2 (0, 5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic systolic heart failure"},{"S-NO":86,"Group name":"Exercise+ milk","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.3(6.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":86,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.7(7.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":87,"Group name":"Aerobic training","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"14.33(2.82)(10-18)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":87,"Group name":"Strength training","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"13.44(3.46)(7-17)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":87,"Group name":"Control","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"14.57(1.81)(12-17)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":87,"Group name":"Aerobic training","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"19.66(6.44)(10-28)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":87,"Group name":"Strength training","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"25.56(9.08)(11-35)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":87,"Group name":"Control","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"20.42(3.33)(14-24)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":88,"Group name":"Total","Depressive disorders classification":"Perinatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Perinatal anxiety","Underlying diseases":"NA"},{"S-NO":89,"Group name":"Depression Subsample,Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.6 (3.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Multiple sclerosis(MS)"},{"S-NO":90,"Group name":"Physical Exercise Program","Depressive disorders classification":"Depressive disorder(single or recurrent depression without psychotic features)","Diagnostic criteria":"ICD-10(F32\/F33)","Depressive symptom degree":"Moderate ","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.2 (3.1)","Treatment protocol":"Medication(47.82%);Psychotherapy(82.61%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":90,"Group name":"Physical Exercise Program","Depressive disorders classification":"Depressive disorder(single or recurrent depression without psychotic features)","Diagnostic criteria":"ICD-10(F32\/F33)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"31.1 (8.1)","Treatment protocol":"Medication(47.82%);Psychotherapy(82.61%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":91,"Group name":"HEART Camp intervention(HC)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PROMIS-29","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"48.1 (8.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Heart failure(HF)(Stage C)"},{"S-NO":92,"Group name":"Zumba dancing","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"31.99(3.42)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Fibromyalgia(FM)"},{"S-NO":92,"Group name":"Aerobic exercise training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30.21(2.98)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Fibromyalgia(FM)"},{"S-NO":93,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)(min-max)","Scale scores(values)":"16.41(1.61)(14\u201020)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":94,"Group name":"Conventional locomotor training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.71(5.38)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Acute cortical\/subcortical ischemic stroke"},{"S-NO":94,"Group name":"Walkbot locomotor training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.86(3.93)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Acute cortical\/subcortical ischemic stroke"},{"S-NO":95,"Group name":"Light","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.1(7.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":95,"Group name":"Moderate","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.8(8.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":95,"Group name":"Hard","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.3(10)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":96,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"At least mild","Rating scale":"GDS","Scale scores(statistical indicators)":"range","Scale scores(values)":">5","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":97,"Group name":"Tai Chi","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-IA","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10 (6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Symptomatic heart failure(HF)(Stage C)"},{"S-NO":97,"Group name":"Resistance band","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-IA","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12 (8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Symptomatic heart failure(HF)(Stage C)"},{"S-NO":98,"Group name":"Video game","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.44(3.16)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":98,"Group name":"Control","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.08(3.52)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":99,"Group name":"HHADS","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)(min-max)","Scale scores(values)":"16.9(3.5)(12-26)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":100,"Group name":"Fibromyalgia(FM)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAD-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.7 (4.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Fibromyalgia (FM)"},{"S-NO":100,"Group name":"Healthy control(HC)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAD-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.1 (3.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":101,"Group name":"Low-dose(LDG)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.73(8.00)","Treatment protocol":"Medication(6.7%)","Drug name":"Venlafaxine","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":101,"Group name":"High-dose(HDG)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.38(7.21)","Treatment protocol":"Medication(7.7%)","Drug name":"Bupropion","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":102,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV-R(SCID;CB-SCID-I\/P)","Depressive symptom degree":"NA","Rating scale":"HAMD-17","Scale scores(statistical indicators)":"range","Scale scores(values)":"14-24","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":102,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV-R(SCID;CB-SCID-I\/P)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"22.31(9.1)(5\u201337)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":103,"Group name":"Depression","Depressive disorders classification":"Depression ","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"61.510 (4.422)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Methamphetamine addicts"},{"S-NO":104,"Group name":"Physical activity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.6(2.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"IgA nephropathy (IgAN)"},{"S-NO":104,"Group name":"Physical activity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"25.2(2.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"IgA nephropathy (IgAN)"},{"S-NO":104,"Group name":"Physical activity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"48.2(11.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"IgA nephropathy (IgAN)"},{"S-NO":105,"Group name":"Experiment","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"36.62(2.37)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Menopausal women"},{"S-NO":106,"Group name":"Exergame","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Diabetes and end-stage renal disease(on hemodialysis)"},{"S-NO":106,"Group name":"Supervised Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Diabetes and end-stage renal disease(on hemodialysis)"},{"S-NO":107,"Group name":"Study","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.34\u200a(2.58)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Congestive heart failure (CHF)(class II-III)"},{"S-NO":108,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.12(3.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Systolic congestive heart failure(SCHF)(class II-III)"},{"S-NO":109,"Group name":"Total","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":110,"Group name":"Pilates","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.33(3.85)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":111,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Kidney-transplanted recipients;Hypertension;Diabetes"},{"S-NO":112,"Group name":"Laughter yoga (LY)","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"ICD-10(F32, F33)","Depressive symptom degree":"NA","Rating scale":"DASS\u201321","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"27.62 (1.99)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":113,"Group name":"Exercise","Depressive disorders classification":"Unipolar depression","Diagnostic criteria":"ICD-10(F32.2,F33.1,F33.2)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.40 (8.53)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":113,"Group name":"Exercise","Depressive disorders classification":"Unipolar depression","Diagnostic criteria":"ICD-10(F32.2,F33.1,F33.2)","Depressive symptom degree":"NA","Rating scale":"HAMD-7","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.00 (3.42)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":114,"Group name":"Intervention","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.8 (3.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":115,"Group name":"Low to moderate intensity exercise program (LMIEP)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.12(3.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Systolic heart failure(HF)(ejection fraction <40%)(class II\u2013III)"},{"S-NO":115,"Group name":"Moderate-intensity exercise program (MICEP)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.34(2.58)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Systolic heart failure(HF)(ejection fraction <40%)(class II\u2013III)"},{"S-NO":116,"Group name":"Resistance training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD-17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.9(8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Parkinson's Disease"},{"S-NO":117,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.14(6.24)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":118,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.14 (1.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Rheumatoid arthritis(RA)"},{"S-NO":118,"Group name":"Control ","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.33 (0.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Rheumatoid arthritis(RA)"},{"S-NO":119,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.1(10.4)","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Mirzapin,Wellbutrin);SSRIs(Trittico,Escitalopram,Citalopram,Fluoxetin,Paroxetin,Cipralex,Seralin);Atypical neuroleptic medication(Quetiapin,Trimipramin)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":120,"Group name":"Medication +Exercise,Older","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"PRIME-MD","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.5 (0.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":120,"Group name":"Medication +Exercise,Younger","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"PRIME-MD","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.5 (6.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":121,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":122,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.15(8.240)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Premenstrual syndrome (PMS)"},{"S-NO":123,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Gastro-esophageal junction adenocarcinoma(stage I\u2013III)"},{"S-NO":124,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.0 (2.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":124,"Group name":"Horticulture","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.0 (2.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":125,"Group name":"Morning exercise(ME)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.52(2.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":125,"Group name":"Evening exercise (EE)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.9(1.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":126,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"HAMD-17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.31(4.99)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":126,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.65(9.83)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":127,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SGDS-K","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.6(0.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":128,"Group name":"Total","Depressive disorders classification":"MDD(single;recurrent)","Diagnostic criteria":"DSM-IV(SCID-1 Research version)","Depressive symptom degree":"Mild\/moderate(36.8%)","Rating scale":"BDI-II","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(67.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":128,"Group name":"Total","Depressive disorders classification":"MDD(single;recurrent)","Diagnostic criteria":"DSM-IV(SCID-1 Research version)","Depressive symptom degree":"Severe(63.2%)","Rating scale":"BDI-II","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(67.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":129,"Group name":"Strength","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SGDS-K","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.0(2.49)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":130,"Group name":"Yoga","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":131,"Group name":"Depression","Depressive disorders classification":"Depressive episode","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.7(2.1)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":132,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.69 (3.36)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Idiopathic Parkinson disease (PD)"},{"S-NO":132,"Group name":"Control ","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.16 (3.64)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Idiopathic Parkinson disease (PD)"},{"S-NO":133,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ-2","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"1.78(1.33)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Tumor disease"},{"S-NO":134,"Group name":"Moderate session","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.1(9.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":134,"Group name":"Preferred session","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.5(9.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":135,"Group name":"Normal weight exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.7(7.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Relapsing-remitting multiple sclerosis(RRMS)"},{"S-NO":135,"Group name":"Overweight exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.9(5.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Relapsing-remitting multiple sclerosis(RRMS)"},{"S-NO":136,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to severe","Rating scale":"HDRS-17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.68 (4.78)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":136,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to severe","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.44 (7.34)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":137,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Prostate cancer(Robot-assisted surgery prostatectomy)"},{"S-NO":138,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.1(10.8)","Treatment protocol":"Medication(97%);Psychotherapy(94%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":139,"Group name":"Moderate-intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D-10","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15 (4.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"HIV"},{"S-NO":139,"Group name":"High-intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D-10","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.6 (4.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"HIV"},{"S-NO":140,"Group name":"High intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-13","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"2.42 (1.12)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":140,"Group name":"High intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS D","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"3.58 (0.86)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":140,"Group name":"High intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"0.49 (0.03)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":140,"Group name":"Low-to-moderate intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-13","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"4.00 (1.24)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":140,"Group name":"Low-to-moderate intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS D","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"4.36 (0.45)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":140,"Group name":"Low-to-moderate intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"0.48 (0.04)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":141,"Group name":"Physical exercise(PE)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.1 (5.9)","Treatment protocol":"Medication(31.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":142,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild(18.2%);Moderate(13.6%)","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.4(6.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":143,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-FS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"2.87 (2.62)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Multiple sclerosis (MS)"},{"S-NO":144,"Group name":"Coordination","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-FS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.96 (6.67)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Multiple sclerosis (MS)"},{"S-NO":144,"Group name":"Workout","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-FS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.92 (5.11)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Multiple sclerosis (MS)"},{"S-NO":145,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.21(5.60)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Chronic pain"},{"S-NO":146,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"ADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.91(4.01)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Ischemic stroke"},{"S-NO":147,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Type 2 Diabetes Mellitus(T2DM)"},{"S-NO":148,"Group name":"Depression","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"28.5(3.8)","Treatment protocol":"Medication","Drug name":"Donarlin;Alprozolan;Bupopriona;Fluoxetina;Revotril;Clonazepam;Sertralina;Venlafaxina;Citalopram;Brintellix","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":149,"Group name":"Total","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":150,"Group name":"Active","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.7(2.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":151,"Group name":"Intervention","Depressive disorders classification":"Perinatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.0(7.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":152,"Group name":"HIIT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.6(5.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":152,"Group name":"SIT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.9(7.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":153,"Group name":"FTB,depression","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.39 (2.03)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":153,"Group name":"Control,depression","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.13 (1.94)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":154,"Group name":"Multiple sclerosis","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"QIDS-SR16","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"8.67(1.76)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Relapsing-remitting multiple sclerosis(RRMS)"},{"S-NO":154,"Group name":"Healthy control","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"QIDS-SR16","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"2.22(0.62)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Relapsing-remitting multiple sclerosis(RRMS)"},{"S-NO":155,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.1(10.91)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Burn patients"},{"S-NO":156,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.9(3.5)","Treatment protocol":"Medication(37%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer(stage I-IIIA or ductal carcinoma in situ)"},{"S-NO":157,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.63 (7.44)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":158,"Group name":"Physical Activity","Depressive disorders classification":"Prenatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.6 (5.3) ","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":158,"Group name":"Usual care","Depressive disorders classification":"Prenatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.7 (5.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":159,"Group name":"Experiment","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.17(3.97)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"HIV(on ART)"},{"S-NO":160,"Group name":"Physical activity intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS\u201312R","Scale scores(statistical indicators)":"mean(median)(SD)","Scale scores(values)":"3.6(2.7)(3.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":161,"Group name":"SIT","Depressive disorders classification":"Major depressive disorder(single episode;recurrent;without psychotic feature)","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"31.8 (10.8)","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Mirzapin,Wellbutrin);SSRIs(Trittico,Escitalopram,Citalopram,Fluoxetin,Paroxetin,Cipralex,Seralin);Atypical neuroleptic medication(Quetiapin,Trimipramin)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":161,"Group name":"CAT","Depressive disorders classification":"Major depressive disorder(single episode;recurrent;without psychotic feature)","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35.2 (10.3)","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Mirzapin,Wellbutrin);SSRIs(Trittico,Escitalopram,Citalopram,Fluoxetin,Paroxetin,Cipralex,Seralin);Atypical neuroleptic medication(Quetiapin,Trimipramin)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":162,"Group name":"MDD","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"37.50 (8.18)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":163,"Group name":"Yoga with medication","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate(57.69%)","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.12(5.00)","Treatment protocol":"Medication","Drug name":"Escitalopram;Fluoxetine;Sertraline;Amitriptyline;Mirtazapine","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":163,"Group name":"Yoga only","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate(75%)","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.88(4.09)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":164,"Group name":"Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"QIDS-SR","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16 (3)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":164,"Group name":"Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"QIDS-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14 (3)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":165,"Group name":"High intensity low volume (HILV) ","Depressive disorders classification":"Major depressive disorder(single episode;recurrent;without psychotic feature)","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.9 (10.9) ","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Mirzapin,Wellbutrin);SSRIs(Trittico,Escitalopram,Citalopram,Fluoxetin,Paroxetin,Cipralex,Seralin);Atypical neuroleptic medication(Quetiapin,Trimipramin)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":165,"Group name":"Moderate continuous aerobic training (MCT)","Depressive disorders classification":"Major depressive disorder(single episode;recurrent;without psychotic feature)","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.8 (8.0)","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Mirzapin,Wellbutrin);SSRIs(Trittico,Escitalopram,Citalopram,Fluoxetin,Paroxetin,Cipralex,Seralin);Atypical neuroleptic medication(Quetiapin,Trimipramin)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":166,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"score","Scale scores(values)":"\u226510","Treatment protocol":"Medication(27.9%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":167,"Group name":"Resistance training1(RT1)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.7 (3.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":167,"Group name":"Resistance training2(RT2)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.7 (3.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":167,"Group name":"Resistance training3(RT3)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.0 (3.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":168,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID I\/II; German version)","Depressive symptom degree":"NA","Rating scale":"BDI-II;MADRS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(85%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":169,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-SF","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.17(3.42)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":171,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"ZSDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"37.4 (9.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Any type of cancer"},{"S-NO":172,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"46.73(1.53)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic low back pain (CLBP)"},{"S-NO":173,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.83(2.72)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":174,"Group name":"Supervised exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.89 (4.20)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Cancer(Breast;Brain;Bladder;Prostate;Kidney)"},{"S-NO":174,"Group name":"Home-based exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.40 (5.27)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Cancer(Breast;Bladder;Prostate)"},{"S-NO":175,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.5(7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Any type of cancer"},{"S-NO":176,"Group name":"SIT","Depressive disorders classification":"Major depressive disorder(single episode;recurrent;without psychotic feature)","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"31(10)","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Mirzapin,Wellbutrin);SSRIs(Trittico,Escitalopram,Citalopram,Paroxetin,Cipralex);Atypical neuroleptic medication(Quetiapin)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":176,"Group name":"CAT","Depressive disorders classification":"Major depressive disorder(single episode;recurrent;without psychotic feature)","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35(10)","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Mirzapin,Wellbutrin);SSRIs(Trittico,Escitalopram,Citalopram,Fluoxetin,Seralin);Atypical neuroleptic medication(Quetiapin,Trimipramin)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":177,"Group name":"Sertraline plus exercise (S+EX)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.0 (2.9)","Treatment protocol":"Medication(64.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":178,"Group name":"Group A(deep neck flexor and home-based exercises)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.95(3.85)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Neck pain"},{"S-NO":178,"Group name":"Group B(superficial muscle and home-based exercises)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.75(3.50)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Neck pain"},{"S-NO":179,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.4(7.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Ischemic stroke"},{"S-NO":180,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"SCID","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"score","Scale scores(values)":"\u226514","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":181,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.5 (14.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":182,"Group name":"Moderate continuous training (MCT)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.4 (8.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":182,"Group name":"HIIT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.2(9.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":182,"Group name":"Control","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.7(9.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":183,"Group name":"Vigorous","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(30.3%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":183,"Group name":"Moderate","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(21.1%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":183,"Group name":"Light","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(20.5%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":184,"Group name":"Experimental","Depressive disorders classification":"Depressive episode","Diagnostic criteria":"ICD-10","Depressive symptom degree":"Mild(5%);Moderate(25%);Severe(70%)","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.30(4.83)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":185,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"DASS-21","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.5(5.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":186,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Autism spectrum disorder(ASD);Mild intellectual disability","Underlying diseases":"NA"},{"S-NO":187,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-5","Depressive symptom degree":"Mild(7%);Moderate(38%);Severe(55%)","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30.83(8.62)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":188,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-5","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.96(6.92)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":189,"Group name":"Participant 1","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"score","Scale scores(values)":"11","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Stroke"},{"S-NO":189,"Group name":"Participant 2","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"score","Scale scores(values)":"6","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Stroke"},{"S-NO":189,"Group name":"Participant 3","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"score","Scale scores(values)":"11","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Stroke"},{"S-NO":190,"Group name":"Human Body Posturizer (HBP)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.5(1.17)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":190,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.6(1.26)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":191,"Group name":"Intervention group 1","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"DASS 21","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"2.2(2.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Coronary artery disease"},{"S-NO":191,"Group name":"Control","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"DASS 21","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.2(3.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Coronary artery disease"},{"S-NO":192,"Group name":"Combined CBT and exercise","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.89 (3.95)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":193,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-5(SCID-5)","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.50(3.94)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Alcohol dependent"},{"S-NO":193,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-5(SCID-5)","Depressive symptom degree":"NA","Rating scale":"QIDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.74(4.98)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Alcohol dependent"},{"S-NO":194,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10(F32.1,F33.1,F34.1)","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":195,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(39%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":196,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"29.77(14.98)","Treatment protocol":"Medication(15%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":197,"Group name":"Aneurysmal subarachnoid haemorrhage (aSAH)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.87(6.57)","Treatment protocol":"Medication(13%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Aneurysmal subarachnoid haemorrhage (aSAH)"},{"S-NO":197,"Group name":"Meningioma","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.63(7.14)","Treatment protocol":"Medication(6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Meningioma"},{"S-NO":197,"Group name":"Healthy","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.35(3.20)","Treatment protocol":"Medication(6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":198,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"DSM-IV(Perinatal Version)(SCID-PN)","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.6(4.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":199,"Group name":"MDD","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"41.75 (3.50)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":200,"Group name":"HILV","Depressive disorders classification":"Major depressive disorder(single episode;recurrent;without psychotic feature)","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"28.8 (9.5)","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Mirzapin);SSRIs(Trittico,Escitalopram,Citalopram,Paroxetin,Cipralex);Atypical neuroleptic medication(Quetiapin,Truxal)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":200,"Group name":"MCT","Depressive disorders classification":"Major depressive disorder(single episode;recurrent;without psychotic feature)","Diagnostic criteria":"ICD-10(F32.1\/2 or F33.1\/2)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.8 (8.5)","Treatment protocol":"Medication","Drug name":"SNRIs(Velafaxin,Wellbutrin);SSRIs(Trittico,Escitalopram,Citalopram,Fluoxetin);Atypical neuroleptic medication(Quetiapin,Truxal)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":201,"Group name":"Light exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.3(7.1)","Treatment protocol":"Medication(22.6%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":201,"Group name":"Moderate exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.8(6.9)","Treatment protocol":"Medication(34.3%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":201,"Group name":"Vigorous exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.4(6.8)","Treatment protocol":"Medication(30.3%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":202,"Group name":"Exercise plus treatment as usual","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID I\/II; German version)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"29.4(10.9)","Treatment protocol":"Medication(77%)","Drug name":"SSRI(23%);SSNRI(23%);NDRI(23%);Agomelatine(27%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":202,"Group name":"Exercise plus treatment as usual","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID I\/II; German version)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.5(8.7)","Treatment protocol":"Medication(77%)","Drug name":"SSRI(23%);SSNRI(23%);NDRI(23%);Agomelatine(27%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":203,"Group name":"Male","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.3(7.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":203,"Group name":"Female","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.4(7.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":204,"Group name":"Female","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.8(8.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Myocardial infarction(MI)"},{"S-NO":205,"Group name":"Light exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild(35.4%);Moderate(60.4%);Severe(4.2%)","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.9(6.3)","Treatment protocol":"Medication(8.3%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":205,"Group name":"Moderate exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild(19.4%);Moderate(77.8%);Severe(2.8%)","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.4(5.3)","Treatment protocol":"Medication(5.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":205,"Group name":"Vigorous exercise","Depressive disorders classification":"Depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild(43.8%);Moderate(53.1%);Severe(3.1%)","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.3(6.0)","Treatment protocol":"Medication(9.4%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":206,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"median(Q1-Q3)","Scale scores(values)":"18.00(12.00-22.50)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":207,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"32.25 (9.42)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":208,"Group name":"Sertraline plus nonprogressive exercise (S+NPE)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.1 (3.2)","Treatment protocol":"Medication(70.3%)","Drug name":"Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":208,"Group name":"Sertraline plus progressive aerobic exercise (S+PAE)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.8 (2.6)","Treatment protocol":"Medication(60.0%)","Drug name":"Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":209,"Group name":"Aerobic exercise (AE)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.5(11.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":209,"Group name":"Placebo exercise (PE)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.3(11.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":210,"Group name":"Exercise intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate to severe","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"11.7(5.4)(4-22)","Treatment protocol":"Medication(60%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":211,"Group name":"Yoga","Depressive disorders classification":"Major depression","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild(20%);Moderate(80%)","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.8 (4.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":212,"Group name":"Better Exercise Adherence after Treatment for Cancer (BEAT Cancer)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.8 (3.3) ","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Breast cancer(stage I-IIIA or ductal carcinoma in situ)"},{"S-NO":213,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.3 (11.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":214,"Group name":"Aerobic exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.28(6.42)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":215,"Group name":"Enhanced EXerCisE thErapy for Parkinson\u2019s Disease (EXCEED)","Depressive disorders classification":"Unipolar major depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.9 (5.3)","Treatment protocol":"Medication(46.7%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Idiopathic Parkinson's disease(PD)"},{"S-NO":215,"Group name":"Self-guided chronic disease self-management plus exercise(SGE)","Depressive disorders classification":"Unipolar major depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.5 (6.1)","Treatment protocol":"Medication(73.3%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Idiopathic Parkinson's disease(PD)"},{"S-NO":216,"Group name":"Physical activity","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.95 (3.68)","Treatment protocol":"Medication(15.8%);Psychotherapy(73.7%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":217,"Group name":"High-dose group (HDG)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.6(6.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":217,"Group name":"Low-dose group (LDG)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.7(8.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":218,"Group name":"Treatment","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"median[interquartil ranges]","Scale scores(values)":"13 [10\u221216]","Treatment protocol":"Medication","Drug name":"SSRI(58%);SNRI(8%);Benzodiazepines(4%);Antiepileptic(4%)","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":219,"Group name":"High dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"QIDS-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.0(2.5)","Treatment protocol":"Medication","Drug name":"SSRI(Citalopram;Escitalopram;Fluoxetine;Paroxetine CR;Sertraline)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":219,"Group name":"Low dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"QIDS-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.0(2.6)","Treatment protocol":"Medication","Drug name":"SSRI(Citalopram;Escitalopram;Fluoxetine;Paroxetine CR;Paroxetine;Sertraline)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":219,"Group name":"High dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"QIDS-SR","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.2(3.6)","Treatment protocol":"Medication","Drug name":"SSRI(Citalopram;Escitalopram;Fluoxetine;Paroxetine CR;Sertraline)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":219,"Group name":"Low dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"QIDS-SR","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.0(4.3)","Treatment protocol":"Medication","Drug name":"SSRI(Citalopram;Escitalopram;Fluoxetine;Paroxetine CR;Paroxetine;Sertraline)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":220,"Group name":"Intervention","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CDI-2","Scale scores(statistical indicators)":"mean","Scale scores(values)":"29.1","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":221,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"QIDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.92(2.9)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":221,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.28(4.23)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":222,"Group name":"Pilates","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(median)(SD)(min-max)","Scale scores(values)":"16.7(15)(6.8)(5-31)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Overweight\/obese"},{"S-NO":222,"Group name":"Walking","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(median)(SD)(min-max)","Scale scores(values)":"18.7(19)(6.9)(6-35)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Overweight\/obese"},{"S-NO":223,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Mild","Rating scale":"GDS-K","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.27(1.43)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":224,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.26(2.11)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Chronic Obstructive Pulmonary Disease (COPD)"},{"S-NO":225,"Group name":"Depressed","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":226,"Group name":"Exercise and behavior","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"1.65 (0.79)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":226,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"1.83 (1.15)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":227,"Group name":"High-intensity","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.89 (1.76)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":227,"Group name":"Moderate-intensity","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.36 (1.43)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":227,"Group name":"Control","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.1 (1.20)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":227,"Group name":"High-intensity","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.67 (3.97)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":227,"Group name":"Moderate-intensity","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.36 (4.27)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":227,"Group name":"Control","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.8 (6.41)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":228,"Group name":"Exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"5.6(6.5)(0\u201331)","Treatment protocol":"Medication(62%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Dementia"},{"S-NO":228,"Group name":"Exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"4.0(3.4)(0\u201313)","Treatment protocol":"Medication(62%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Dementia"},{"S-NO":229,"Group name":"Exercise","Depressive disorders classification":"Recurrent depressive disorder, moderate current episode;Dysthymia","Diagnostic criteria":"ICD-10(F33.1;F34.1)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"45.29(10.47)","Treatment protocol":"Medication","Drug name":"SSRIs;Fluoxetine;Escitalopram;Sertraline;Paroxetine;Diazepam;Lorazepam;Estazolam","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":230,"Group name":"Total ","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CDI ","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":231,"Group name":"Total ","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.36(3.11)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Multiple sclerosis (MS)"},{"S-NO":232,"Group name":"Total ","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Mild(23%);Moderate(77%)","Rating scale":"MADRS","Scale scores(statistical indicators)":"median(range)","Scale scores(values)":"23(15-29)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":233,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"DASS-21","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.66(8.92)","Treatment protocol":"Medication(40.4%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":234,"Group name":"Women","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.25 (6.38)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":234,"Group name":"Men","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.40 (7.52)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":235,"Group name":"Total ","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.5(9.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"End stage renal disease (ESRD) "},{"S-NO":235,"Group name":"Total ","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.5(9.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"End stage renal disease (ESRD) "},{"S-NO":236,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.2(6.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":237,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.0(10.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":238,"Group name":"High dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.0 (4.0)","Treatment protocol":"Medication","Drug name":"SSRI(Citalopram;Escitalopram;Fluoxetine;Paroxetine CR;Sertraline)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":238,"Group name":"Low dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.2 (3.8)","Treatment protocol":"Medication","Drug name":"SSRI(Citalopram;Escitalopram;Fluoxetine;Paroxetine CR;Paroxetine;Sertraline)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":238,"Group name":"High dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"IDS-C30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.8 (7.5)","Treatment protocol":"Medication","Drug name":"SSRI(Citalopram;Escitalopram;Fluoxetine;Paroxetine CR;Sertraline)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":238,"Group name":"Low dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"IDS-C30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35.1 (7.6)","Treatment protocol":"Medication","Drug name":"SSRI(Citalopram;Escitalopram;Fluoxetine;Paroxetine CR;Paroxetine;Sertraline)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":239,"Group name":"Physical exercise","Depressive disorders classification":"Depressive episode;Recurrent depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.2 (6.9)","Treatment protocol":"Medication(31%)","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety disorder","Underlying diseases":"NA"},{"S-NO":240,"Group name":"Light exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.3(7.1)","Treatment protocol":"Medication(22.6%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder;Subthreshold affective disorder","Underlying diseases":"NA"},{"S-NO":240,"Group name":"Moderate exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.8(6.9)","Treatment protocol":"Medication(34.3%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder;Subthreshold affective disorder","Underlying diseases":"NA"},{"S-NO":240,"Group name":"Vigorous exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.4(6.8)","Treatment protocol":"Medication(30.3%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder;Subthreshold affective disorder","Underlying diseases":"NA"},{"S-NO":241,"Group name":"Aerobic interval training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean","Scale scores(values)":"2.8","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Stable ischaemic heart failure(HF)"},{"S-NO":242,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.4(8.1)","Treatment protocol":"Medication(85%)","Drug name":"SSRI(35%);SSNRI(20%);NDRI(20%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":242,"Group name":"Control","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.8(9.8)","Treatment protocol":"Medication(90%)","Drug name":"SSRI(50%);SSNRI(30%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":242,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30.5(10.6)","Treatment protocol":"Medication(85%)","Drug name":"SSRI(35%);SSNRI(20%);NDRI(20%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":242,"Group name":"Control","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30.0(8.5)","Treatment protocol":"Medication(90%)","Drug name":"SSRI(50%);SSNRI(30%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":243,"Group name":"Patients","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(76%)","Drug name":"SSRI;SSNRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":244,"Group name":"Aerobic exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"36.1 (5.9)","Treatment protocol":"Medication","Drug name":"SSRI(paroxetine,fluoxetine)(64.3%);SSNRI(milnacipran)(21.4%);Dopamine agonist(bupropion)(14.3%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":244,"Group name":"Stretching exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"37.8 (8.3)","Treatment protocol":"Medication","Drug name":"SSRI(paroxetine,fluoxetine)(72.7%);SSNRI(milnacipran)(18.2%);Dopamine agonist(bupropion)(9.1%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":245,"Group name":"Light","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.2(7.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":245,"Group name":"Moderate","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.6(9.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":245,"Group name":"Hard","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.1(9.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":245,"Group name":"Preferred","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.4(8.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":246,"Group name":"Light","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.2 (7.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":246,"Group name":"Moderate","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.6 (9.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":246,"Group name":"Hard","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.1 (9.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":247,"Group name":"Light","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.2 (7.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":247,"Group name":"Moderate","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.6 (9.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":247,"Group name":"Hard","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.1 (9.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":248,"Group name":"Yoga with medication","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.47(5.43)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":248,"Group name":"Yoga only","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.84(4.10)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":249,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean","Scale scores(values)":"5.73","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":250,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.25(8.47)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic obstructive pulmonary disease (COPD)"},{"S-NO":251,"Group name":"Atypical","Depressive disorders classification":"Major depressive disorder(non-remitted)","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"IDS-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"38.34 (6.9)","Treatment protocol":"Medication","Drug name":"SSRI ","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":251,"Group name":"Non-Atypical","Depressive disorders classification":"Major depressive disorder(non-remitted)","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"IDS-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"32.30 (7.0)","Treatment protocol":"Medication","Drug name":"SSRI ","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":252,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"2.86(0.52)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":253,"Group name":"Aerobic exercise ","Depressive disorders classification":"Depression","Diagnostic criteria":"SCID","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.12(3.61)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":254,"Group name":"Electroconvulsive therapy (ECT) + Aerobic exercise training (AET)","Depressive disorders classification":"Depressive disorder(unipolar)","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"39.05 (8.41)","Treatment protocol":"Medication","Drug name":"SSRI ","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":254,"Group name":"Aerobic exercise training (AET)","Depressive disorders classification":"Depressive disorder(unipolar)","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"34.15 (8.51)","Treatment protocol":"Medication","Drug name":"SSRI ","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":254,"Group name":"Electroconvulsive therapy (ECT) + Aerobic exercise training (AET)","Depressive disorders classification":"Depressive disorder(unipolar)","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"44.65 (8.13)","Treatment protocol":"Medication","Drug name":"SSRI ","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":254,"Group name":"Aerobic exercise training (AET)","Depressive disorders classification":"Depressive disorder(unipolar)","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"40.35 (8.35)","Treatment protocol":"Medication","Drug name":"SSRI ","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":255,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.04(7.17)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Type 2 Diabetes Mellitus(T2DM)"},{"S-NO":256,"Group name":"Taiji","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"ADS\u2010K","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.46(6.90)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":257,"Group name":"Behavioral activation and exercise condition(EX)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-IV)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.7 (4.6)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Type 2 Diabetes Mellitus(T2DM)"},{"S-NO":257,"Group name":"Behavioral activation and exercise condition(EX)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-IV)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.5 (8.2)","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Type 2 Diabetes Mellitus(T2DM)"},{"S-NO":258,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.20(6.60)","Treatment protocol":"Medication(45.0%);Psychotherapy(5.0%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":258,"Group name":"Walking control","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.50(4.31)","Treatment protocol":"Medication(60.0%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":259,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":260,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Moderate to severe","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.20(3.14)","Treatment protocol":"Medication(69%)","Drug name":"Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":260,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"29.51(9.46)","Treatment protocol":"Medication(69%)","Drug name":"Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":260,"Group name":"Control","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Moderate to severe","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.92(9.64)","Treatment protocol":"Medication(72%)","Drug name":"Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":261,"Group name":"16 kcals","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.6 (3.6)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":261,"Group name":"16 kcals","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"IDS-C30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.2 (7.1)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":261,"Group name":"4 kcals","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.0 (3.8)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":261,"Group name":"4 kcals","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"IDS-C30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"34.7 (7.8)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":262,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.64(2.044)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":263,"Group name":"Sertraline + exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.1(3.1)","Treatment protocol":"Medication","Drug name":"Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":264,"Group name":"Yoga","Depressive disorders classification":"Prenatal depression(Current major depression;Past major depression in preg.)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Moderate","Rating scale":"QIDS-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.17(2.52)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":264,"Group name":"Yoga","Depressive disorders classification":"Prenatal depression(Current major depression;Past major depression in preg.)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Moderate","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.16(4.76)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":265,"Group name":"Total","Depressive disorders classification":"Major depressive disorder(recurrent,chronic);Bipolar 2 disorder(depressed;chronic)","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"median(IQR)","Scale scores(values)":"16(8)","Treatment protocol":"Medication(100%);Cognitive behavioural therapy(93%);Psychotherapy(47%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":266,"Group name":"Multicomponent","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.9(2.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":266,"Group name":"Resistance","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.9(2.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":267,"Group name":"Total","Depressive disorders classification":"Prenatal depression(Current MDD;MDD earlier in pregnancy;Current minor depressive disorder;Minor depressive disorder earlier in preg.)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to moderate","Rating scale":"QIDS","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"12.6 (3.2)(7-18)","Treatment protocol":"Medication(3%);Psychotherapy(12%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":267,"Group name":"Total","Depressive disorders classification":"Prenatal depression(Current MDD;MDD earlier in pregnancy;Current minor depressive disorder;Minor depressive disorder earlier in preg.)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to moderate","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"13.0 (5.3)(2-23)","Treatment protocol":"Medication(3%);Psychotherapy(12%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":268,"Group name":"Progressive aerobic exercise plus sertraline(S+PAE)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD),median (IQR)","Scale scores(values)":"19.8 (2.6),18(18\u201321)","Treatment protocol":"Medication(60%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":268,"Group name":"Non-progressive exercise plus sertraline (S+NPE)","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD),median (IQR)","Scale scores(values)":"20.1 (3.2),18(18\u201322)","Treatment protocol":"Medication(70%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":269,"Group name":"Exercise and counseling","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.7 (3.1)","Treatment protocol":"Medication(74.2%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":270,"Group name":"Exercise","Depressive disorders classification":"Perinatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.96 (3.09)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":271,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.03(5.17)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":272,"Group name":"Yoga","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.33 (5.10)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":272,"Group name":"Yoga","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"IDAS General Depression scale","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"58.19 (9.10)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":273,"Group name":"Exercise","Depressive disorders classification":"Depressive episode(moderate);Recurrent depressive disorder,moderate current episode;Dysthymia","Diagnostic criteria":"ICD-10(F32.1,F33.1,F34.1)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"45.56(9.65)","Treatment protocol":"Medication","Drug name":"SSRls(Fluoxetine; Escitalopram; Sertraline; Paroxetine)","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":273,"Group name":"Exercise","Depressive disorders classification":"Depressive episode(moderate);Recurrent depressive disorder,moderate current episode;Dysthymia","Diagnostic criteria":"ICD-10(F32.1,F33.1,F34.1)","Depressive symptom degree":"NA","Rating scale":"DASS-21","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.78(6.82)","Treatment protocol":"Medication","Drug name":"SSRls(Fluoxetine; Escitalopram; Sertraline; Paroxetine)","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":274,"Group name":"Intervention","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CDI-2","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"29.1 (9.4)","Treatment protocol":"Counselling alone(40.9%);CBT alone(2.3%);Support(2.3%);Counselling and medication(2.3%);CBT and medication(2.3%);Medication(4.5%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":275,"Group name":"Walking-exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.67(3.57)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Primary lung cancer"},{"S-NO":276,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression(major depressive episode)","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.3 (3.0)","Treatment protocol":"Medication(22%);Counselling\/psychological support(7%);Medication and counselling\/psychological support(2%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":277,"Group name":"Yoga","Depressive disorders classification":"Perinatal depression","Diagnostic criteria":"DSM(SCID-RV)","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.13(4.46)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Perinatal anxiety","Underlying diseases":"NA"},{"S-NO":278,"Group name":"MDD","Depressive disorders classification":"Major depressive disorder(Current major depressive episode)","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.75(11.02)","Treatment protocol":"Medication","Drug name":"Venlafaxine;Amitriptyline;Prazepam;Cyame\u00b4mazine;Zopiclone;Alprazolam;Naltrexone;Sodic levothyroxine;Melatonine;Divalproate Sodium;Escitalopram;Quetiapine;Loprazolam;Paroxetine;Fluoxetine;Sertraline;Clomipramine;Agomelatine;Mianserine;Amoxapine;Aripiprazole;Bromazepam","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":279,"Group name":"Intervention","Depressive disorders classification":"Depressive episode","Diagnostic criteria":"ICD-10(F32.1,F32.2,F33.0,F33.1,F33.2)","Depressive symptom degree":"Mild to severe","Rating scale":"HRSD-17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.97(2.58)","Treatment protocol":"Medication(50%);Psychotherapy(53.3%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":279,"Group name":"Intervention","Depressive disorders classification":"Depressive episode","Diagnostic criteria":"ICD-10(F32.1,F32.2,F33.0,F33.1,F33.2)","Depressive symptom degree":"Mild to severe","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.10(8.11)","Treatment protocol":"Medication(50%);Psychotherapy(53.3%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":280,"Group name":"High dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-CV)","Depressive symptom degree":"NA","Rating scale":"HRSD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.7(4.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":280,"Group name":"Low dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-CV)","Depressive symptom degree":"NA","Rating scale":"HRSD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.1(4.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":280,"Group name":"High dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-CV)","Depressive symptom degree":"NA","Rating scale":"IDS-C30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"37.1(7.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":280,"Group name":"Low dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-CV)","Depressive symptom degree":"NA","Rating scale":"IDS-C30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"37.9(8.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":280,"Group name":"High dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-CV)","Depressive symptom degree":"NA","Rating scale":"IDS-SR30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.3(8.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":280,"Group name":"Low dose","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-CV)","Depressive symptom degree":"NA","Rating scale":"IDS-SR30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35.9(10.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":281,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean","Scale scores(values)":"13.7","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Methamphetamine dependence"},{"S-NO":282,"Group name":"Physical exercise","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.2 (6.8)","Treatment protocol":"Medication(31%)","Drug name":"SSRIs","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":283,"Group name":"Physical fitness exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.63 (3.56)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":284,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I\/II)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.5(8.7)","Treatment protocol":"Medication(77%);Psychotherapy(100%);Cognitive behavioral therapy(100%)","Drug name":"SSRI(23%);SSNRI(23%);NDRI(23%);Agomelatine(27%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":284,"Group name":"Treatment as usual","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I\/II)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.5(10.3)","Treatment protocol":"Medication(75%);Psychotherapy(100%);Cognitive behavioral therapy(100%)","Drug name":"SSRI(25%);SSNRI(25%);NDRI(20%);Agomelatine(20%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":284,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I\/II)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"29.4(10.9)","Treatment protocol":"Medication(77%);Psychotherapy(100%);Cognitive behavioral therapy(100%)","Drug name":"SSRI(23%);SSNRI(23%);NDRI(23%);Agomelatine(27%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":284,"Group name":"Treatment as usual","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I\/II)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"28.3(11.2)","Treatment protocol":"Medication(75%);Psychotherapy(100%);Cognitive behavioral therapy(100%)","Drug name":"SSRI(25%);SSNRI(25%);NDRI(20%);Agomelatine(20%)","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":285,"Group name":"Nordic walking","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-SF","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"2.25 (2.18)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":285,"Group name":"General exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-SF","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.5 (2.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":286,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.4(0.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Parkinson's disease"},{"S-NO":287,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.8 (13.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":288,"Group name":"Medication-and-exercise","Depressive disorders classification":"Major depressive disorder;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.8 (3.7)","Treatment protocol":"Medication","Drug name":"Sertraline;Alprazolam","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":289,"Group name":"Exercise","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HAMD;MDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication","Drug name":"Duloxetine;Venlafaxine;Sertraline;;Fluoxetine;Zopiclone;Melatonin;Clonazepam;Oxazepam;Mianserin;Mirtazapine;Lithium in mmol;Lamotrigine;Quetiapin;Pregabalin","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":290,"Group name":"Exercise during pregnancy","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.77(3.86)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":290,"Group name":"Exercise during pregnancy and post-partum period","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.07(3.91)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":291,"Group name":"Exercise","Depressive disorders classification":"Prenatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.87(8.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":292,"Group name":"Physical exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.5 (8.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Type 2 diabetes"},{"S-NO":293,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.3 (3.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Advanced-stage lung cancer"},{"S-NO":294,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.1(6.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer(newly diagnosed,stage II and III)"},{"S-NO":295,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.7(5.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Methamphetamine-dependent"},{"S-NO":296,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.80(10.29)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":297,"Group name":"Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"Severe","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.52(1.8)","Treatment protocol":"Medication(NA%);Electroconvulsive Therapy(NA%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":298,"Group name":"Aerobic","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"29.00(5.06)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":298,"Group name":"Stretching","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.50(7.66)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":298,"Group name":"Aerobic","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"28.33(6.28)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":298,"Group name":"Stretching","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35.33(5.28)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":299,"Group name":"Physical exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.5 (8.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Type 2 diabetes"},{"S-NO":300,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"28.00(2.98)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer"},{"S-NO":300,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"27.00(2.78)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer"},{"S-NO":301,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.18(5.91)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":302,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"ZSDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"37.47(5.66)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Breast cancer"},{"S-NO":303,"Group name":"Experimental","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.7(8.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Ischemic stroke"},{"S-NO":304,"Group name":"Experimental","Depressive disorders classification":"Major depressive disorder;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.4(2.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Stroke"},{"S-NO":304,"Group name":"Control","Depressive disorders classification":"Major depressive disorder;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.1(2.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Stroke"},{"S-NO":305,"Group name":"Yoga","Depressive disorders classification":"Perinatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.29(3.14)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":306,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"32.36(1.50)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Intellectual disabilities"},{"S-NO":307,"Group name":"Qigong","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.4 (3.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic fatigue syndrome(CFS)"},{"S-NO":308,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"HAM-D","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":309,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":310,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Coronary heart disease (CHD) and\/or type 2 diabetes"},{"S-NO":311,"Group name":"Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.6(4.1)","Treatment protocol":"Medication","Drug name":"Tricyclics;SSRIs;SNRI;Other","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":311,"Group name":"Basic body awareness therapy","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.9(5.0)","Treatment protocol":"Medication","Drug name":"SSRIs;SNRI;Other","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":311,"Group name":"Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"MADRS-S","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.1(6.2)","Treatment protocol":"Medication","Drug name":"Tricyclics;SSRIs;SNRI;Other","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":311,"Group name":"Basic body awareness therapy","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"MADRS-S","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"25.3(6.2)","Treatment protocol":"Medication","Drug name":"SSRIs;SNRI;Other","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":312,"Group name":"Major depression","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.92 (7.56)","Treatment protocol":"Medication(26.3%)","Drug name":"NA","Comorbidity(mental disease)":"Generalized anxiety disorder;Panic disorder;Posttraumatic stress disorder;Social phobia;Specific phobia","Underlying diseases":"NA"},{"S-NO":313,"Group name":"Depression","Depressive disorders classification":"Bipolar depression;Depressive episode or recurrent depression;Dysthymia","Diagnostic criteria":"ICD-10(F31.3;F32,F33;F34.1)","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":314,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.23(10.48)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":314,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"C-BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.15(10.63)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":315,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder;Dysthymia","Diagnostic criteria":"MINI","Depressive symptom degree":"Moderate to severe","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.67 (4.58)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":316,"Group name":"Resistance training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.5(6.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":316,"Group name":"Flexibility training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":317,"Group name":"Exercise and psychotherapy","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"4.24(0.62)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":318,"Group name":"Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD-17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.0 (3.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety","Underlying diseases":"NA"},{"S-NO":318,"Group name":"Control","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD-17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.9 (4.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety","Underlying diseases":"NA"},{"S-NO":319,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.67(6.78)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":320,"Group name":"Total","Depressive disorders classification":"Depression;Subthreshold depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.0 (12.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":321,"Group name":"Antenatal yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"5 (2\u201310)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":321,"Group name":"Antenatal yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"5 (2\u201310)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Pregnancy-specific anxiety","Underlying diseases":"NA"},{"S-NO":322,"Group name":"Physical exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"NA","Scale scores(values)":"25.50(11.83)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":323,"Group name":"Physical activity","Depressive disorders classification":"Major depressive episode;Minor depressive illness","Diagnostic criteria":"DSM-IV(SCID-I-RV)","Depressive symptom degree":"NA","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean","Scale scores(values)":"21.02","Treatment protocol":"Medication(60.2%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":324,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"32.80 (7.97)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":324,"Group name":"ECT+exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"39.05 (8.41)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":324,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"38.20 (8.92)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":324,"Group name":"ECT+exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"44.65 (8.13)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":325,"Group name":"Yoga","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV(296.2 or 296.3)","Depressive symptom degree":"NA","Rating scale":"HAMD-21","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.73(6.54)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":326,"Group name":"Young","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.50(5.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":326,"Group name":"Postmenopausal","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.91(4.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":327,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.68 (2.6)","Treatment protocol":"Medication(80%)","Drug name":"SSRI;Tricyclic;Mood stabilizer;","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":328,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Breast cancer(Stages 1-3)"},{"S-NO":329,"Group name":"Qigong","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.1 (2.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic fatigue syndrome-like illness"},{"S-NO":330,"Group name":"Exercise\/music","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.5(2.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":331,"Group name":"Supervised exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.75(6.69)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer"},{"S-NO":331,"Group name":"Home exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.05(8.18)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer"},{"S-NO":332,"Group name":"Tai chi\/yoga","Depressive disorders classification":"Prenatal depression(Dysthymia or major depression)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"32.4 (10.2) ","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":333,"Group name":"Yoga","Depressive disorders classification":"Prenatal depression(Dysthymia or major depression)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.0 (10.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":333,"Group name":"Yoga","Depressive disorders classification":"Prenatal depression(Dysthymia or major depression)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.5 (5.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":333,"Group name":"Yoga","Depressive disorders classification":"Prenatal depression(Dysthymia or major depression)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"POMS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.7 (13.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":334,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.85(7.93)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":335,"Group name":"Yoga","Depressive disorders classification":"Major depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.0(4.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":335,"Group name":"Combination","Depressive disorders classification":"Major depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.2(4.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":336,"Group name":"Major depression","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.97(9.61)","Treatment protocol":"Medication(23.7%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":337,"Group name":"Vigorous exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"CDRS-R","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"50.9 (47.5-54.2)","Treatment protocol":"Medication(4%)","Drug name":"Citalopram","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":337,"Group name":"Stretching","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"CDRS-R","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"53.6 (49.9-57.2)","Treatment protocol":"Medication(4%)","Drug name":"Fluoxetine","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":337,"Group name":"Vigorous exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-Clinician report","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"13.3 (11.8-14.8)","Treatment protocol":"Medication(4%)","Drug name":"Citalopram","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":337,"Group name":"Stretching","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-Clinician report","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"14.4 (12.8-16.0)","Treatment protocol":"Medication(4%)","Drug name":"Fluoxetine","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":337,"Group name":"Vigorous exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-Self-Report","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"9.1 (6.1-12.0)","Treatment protocol":"Medication(4%)","Drug name":"Citalopram","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":337,"Group name":"Stretching","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-Self-Report","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"10.0 (6.8-13.2)","Treatment protocol":"Medication(4%)","Drug name":"Fluoxetine","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":337,"Group name":"Vigorous exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-Parent report","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"10.0 (8.0-12.0)","Treatment protocol":"Medication(4%)","Drug name":"Citalopram","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":337,"Group name":"Stretching","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-Parent report","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"12.8 (10.6-14.9)","Treatment protocol":"Medication(4%)","Drug name":"Fluoxetine","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":338,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HRSD-17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.4(4.9)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":339,"Group name":"Yoga","Depressive disorders classification":"Major depressive disorder;Dysthymia","Diagnostic criteria":"MINI","Depressive symptom degree":"Moderate to severe","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.67 (4.58)","Treatment protocol":"Medication(60%);Psychotherapy(73.33%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":340,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"median(interquartile range)","Scale scores(values)":"31.0 (27.0\u201337.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Paroxysmal atrial fibrillation"},{"S-NO":341,"Group name":"MDD","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.90 (5.74)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":342,"Group name":"Yoga","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.8(4.1)","Treatment protocol":"Medication(57.9%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":342,"Group name":"Yoga + medications","Depressive disorders classification":"Depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.3(5.3)","Treatment protocol":"Medication(68.2%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":343,"Group name":"Muscle strengthening exercises","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.76(3.04)","Treatment protocol":"Medication(20%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":343,"Group name":"Aerobic exercises","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.21(2.71)","Treatment protocol":"Medication(18%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":344,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.1(3.8)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":344,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.8(3.8)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":345,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"IDS-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35.15 (7.88)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":345,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"IDS-C","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.15 (6.49)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":345,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"IDS-SR","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.62 (10.67)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":345,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"IDS-SR","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"31.68 (7.84)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":345,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.42 (3.94)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":345,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.79 (3.80) ","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":346,"Group name":"Yoga","Depressive disorders classification":"Prenatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.39(2.55)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Prenatal anxiety","Underlying diseases":"NA"},{"S-NO":346,"Group name":"Control","Depressive disorders classification":"Prenatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.73(2.22)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Prenatal anxiety","Underlying diseases":"NA"},{"S-NO":347,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Hare-Davis","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"94.7(17.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Systolic heart failure(HF)(NYHA class II or III)"},{"S-NO":348,"Group name":"Qigong","Depressive disorders classification":"Major depressive disorder;Depressive symptoms","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.71(3.30)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":348,"Group name":"Qigong","Depressive disorders classification":"Major depressive disorder;Depressive symptoms","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.81(6.58)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":349,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAD-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14(4.47)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Neurological disorders"},{"S-NO":350,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.8 (3.3)","Treatment protocol":"Medication(28%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":351,"Group name":"Exercise and psycho-education","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.91(11.83)","Treatment protocol":"Medication;Psychotherapy;(38.2%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":351,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"25.69(12.30)","Treatment protocol":"Medication;Psychotherapy;(32.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":352,"Group name":"Aerobic exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.58(7.40)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":353,"Group name":"Aerobic exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"median (Q1, Q3)","Scale scores(values)":"8 (5, 15)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Stable heart failure(HF)(NYHA class II to IV)"},{"S-NO":354,"Group name":"Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.5 (7.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Coronary heart disease (CHD)"},{"S-NO":354,"Group name":"Exercise","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAM-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.4 (5.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Coronary heart disease (CHD)"},{"S-NO":355,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.8(10.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Type 2 diabetes"},{"S-NO":356,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS 15","Scale scores(statistical indicators)":"median (IQR)","Scale scores(values)":"3.5 (2.0, 5.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic poststroke hemiparesis"},{"S-NO":356,"Group name":"Yoga and exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS 15","Scale scores(statistical indicators)":"median (IQR)","Scale scores(values)":"4.0 (1.5, 7.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic poststroke hemiparesis"},{"S-NO":357,"Group name":"Total","Depressive disorders classification":"Major depressive disorder;Depressive Disorder,Not Otherwise Specified","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CDRS-R","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"48.9(9.7)","Treatment protocol":"Medication(46%)","Drug name":"SSRI","Comorbidity(mental disease)":"Anxiety Disorder;ADHD","Underlying diseases":"NA"},{"S-NO":357,"Group name":"Total","Depressive disorders classification":"Major depressive disorder;Depressive Disorder,Not Otherwise Specified","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"QIDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.2(4.5)","Treatment protocol":"Medication(46%)","Drug name":"SSRI","Comorbidity(mental disease)":"Anxiety Disorder;ADHD","Underlying diseases":"NA"},{"S-NO":358,"Group name":"Yoga","Depressive disorders classification":"Prenatal depression(dysthymia or major depressive disorder)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"28.35(8.86)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":359,"Group name":"Major depression","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.89 (10.57)","Treatment protocol":"Medication(26.3%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":360,"Group name":"Strength","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Beackes\u2019 depression questionnaire","Scale scores(statistical indicators)":"mean","Scale scores(values)":"11.53","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":360,"Group name":"Endurance","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Beackes\u2019 depression questionnaire","Scale scores(statistical indicators)":"mean","Scale scores(values)":"9.76","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":361,"Group name":"Aerobic exercise","Depressive disorders classification":"Major depression(single;recurrent)","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HAM-D17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.2 (4.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety","Underlying diseases":"NA"},{"S-NO":361,"Group name":"Stretching exercise","Depressive disorders classification":"Major depression(single;recurrent)","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HAM-D17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.6 (4.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety","Underlying diseases":"NA"},{"S-NO":361,"Group name":"Aerobic exercise","Depressive disorders classification":"Major depression(single;recurrent)","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HAM-D6","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.6 (2.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety","Underlying diseases":"NA"},{"S-NO":361,"Group name":"Stretching exercise","Depressive disorders classification":"Major depression(single;recurrent)","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HAM-D6","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.2 (2.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety","Underlying diseases":"NA"},{"S-NO":361,"Group name":"Aerobic exercise","Depressive disorders classification":"Major depression(single;recurrent)","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35.7 (7.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety","Underlying diseases":"NA"},{"S-NO":361,"Group name":"Stretching exercise","Depressive disorders classification":"Major depression(single;recurrent)","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"35.5 (8.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Generalised anxiety","Underlying diseases":"NA"},{"S-NO":362,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.6 (9.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":363,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-II);MINI","Depressive symptom degree":"NA","Rating scale":"HDRS17","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"22.3(0.62)","Treatment protocol":"Medication(84.2%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":364,"Group name":"Medical exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAD-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.0 (2.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Degenerative meniscus injury"},{"S-NO":365,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.0(5.90)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Menstrual irregularities"},{"S-NO":366,"Group name":"Patient 1","Depressive disorders classification":"Dysthymic disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ;BDI-II","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication;Psychotherapy","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":366,"Group name":"Patient 2","Depressive disorders classification":"Adjustment disorder with depressed mood","Diagnostic criteria":"DSM","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ;BDI-II","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":366,"Group name":"Patient 3","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"DSM","Depressive symptom degree":"Mild to moderate","Rating scale":"PHQ;BDI-II","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder NOS","Underlying diseases":"NA"},{"S-NO":367,"Group name":"Exercise","Depressive disorders classification":"Prenatal depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16 (8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":368,"Group name":"Patient 1","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate to severe","Rating scale":"HAMD","Scale scores(statistical indicators)":"value","Scale scores(values)":"26","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Traumatic brain injury"},{"S-NO":368,"Group name":"Patient 2","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate to severe","Rating scale":"HAMD","Scale scores(statistical indicators)":"value","Scale scores(values)":"23","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Traumatic brain injury"},{"S-NO":368,"Group name":"Patient 3","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate to severe","Rating scale":"HAMD","Scale scores(statistical indicators)":"value","Scale scores(values)":"19","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Traumatic brain injury"},{"S-NO":368,"Group name":"Patient 4","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate to severe","Rating scale":"HAMD","Scale scores(statistical indicators)":"value","Scale scores(values)":"27","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Traumatic brain injury"},{"S-NO":369,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":370,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.13(8.82)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic low back pain"},{"S-NO":370,"Group name":"Physical exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.05(6.53)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic low back pain"},{"S-NO":371,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.09(3.64)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Severely obese"},{"S-NO":372,"Group name":"Preferred intensity","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.5 (10.7)","Treatment protocol":"Medication(78.9%);Talking therapy(31.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":372,"Group name":"Prescribed intensity","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30.5 (12.0)","Treatment protocol":"Medication(89.5%);Talking therapy(57.9%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":373,"Group name":"Exercise and pharmacotherapy","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10","Depressive symptom degree":"Moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.29(2.51)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":374,"Group name":"Total","Depressive disorders classification":"Major depressive disorder(single;recurrent)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"NA","Rating scale":"HAM-D","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":375,"Group name":"Physical training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.5(4.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Any type of cancer"},{"S-NO":375,"Group name":"Physical training and CBT","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.8(4.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Any type of cancer"},{"S-NO":376,"Group name":"Total","Depressive disorders classification":"Major depression","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(NA%)","Drug name":"Sertraline hydrochloride","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":377,"Group name":"HiMF training(high numbers of metabolic risk factors)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Cardiac Depression Scale","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"82.6(5.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":377,"Group name":"LoMF training(low number of metabolic risk factors)","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Cardiac Depression Scale","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"65.5(7.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":378,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.17 (3.83)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Primary non-metastatic breast cancer"},{"S-NO":379,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.43(2.90)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Any type of cancer"},{"S-NO":380,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Kellner Symptom Questionnaire","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.0(3.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Heart failure(HF)(Stage C)"},{"S-NO":381,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.32 (1.69)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":381,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.68 (2.07)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":382,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HAMD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"25.6(2.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":383,"Group name":"Laughter Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.0(5.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":383,"Group name":"Exercise therapy","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.3(5.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.8 (3.8)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HDRS17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.1 (3.8)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"IDS-C30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.3 (7.1)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"IDS-C30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"34.7 (7.8)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-C16","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.9 (2.6)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-C16","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.0 (2.6)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"IDS-SR30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"31.7 (8.2)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"IDS-SR30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"33.1 (10.9)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"16KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-SR16","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.2 (3.6)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":384,"Group name":"4KKW","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"QIDS-SR16","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.0 (4.3)","Treatment protocol":"Medication","Drug name":"SSRI","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":385,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Mild to moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.1 (3.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":386,"Group name":"Isokinetic exercises + Shortwave diathermy","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.50(4.68)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Knee osteoarthritis (OA)"},{"S-NO":386,"Group name":"Isokinetic exercises","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.45(5.23)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Knee osteoarthritis (OA)"},{"S-NO":387,"Group name":"Yoga exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Taiwanese Depression Questionnaire","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.10(9.45)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Transitional frail elders"},{"S-NO":388,"Group name":"High-intensity functional weight-bearing exercise programme","Depressive disorders classification":"Depression","Diagnostic criteria":"DSM-IV ","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"4.6(3.4)(0-14)","Treatment protocol":"Medication(51%)","Drug name":"NA","Comorbidity(mental disease)":"Dementia disorder","Underlying diseases":"NA"},{"S-NO":389,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV ","Depressive symptom degree":"NA","Rating scale":"BDI;HDRS;MADRS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":390,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"2.5(1.7)","Treatment protocol":"Medication(40%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Current stroke"},{"S-NO":391,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.29(6.71)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":391,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.63(2.60)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":392,"Group name":"Strength training","Depressive disorders classification":"Clinical depression","Diagnostic criteria":"ICD-10(F32.0,F32.1,F33.0,F33.1)","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.6 (3.5)","Treatment protocol":"Medication(62.1%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":392,"Group name":"Aerobic training","Depressive disorders classification":"Clinical depression","Diagnostic criteria":"ICD-10(F32.0,F32.1,F33.0,F33.1)","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.4 (4.2)","Treatment protocol":"Medication(64.5%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":393,"Group name":"Intervention","Depressive disorders classification":"Depression;Depression,recurrent","Diagnostic criteria":"ICD-10(F32.0,F32.1;F33.0,F33.1)","Depressive symptom degree":"Mild and moderate","Rating scale":"HAMD","Scale scores(statistical indicators)":"median(range)","Scale scores(values)":"19 (13\u201328)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":394,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"4.60(3.55)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":395,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.0(6.1)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":396,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"QIDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.00(2.91)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline;Citalopram;Venlafaxine;Buproprion;Escitalopram;Duloxetine","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":396,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to severe","Rating scale":"PHQ-9","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.40(4.27)","Treatment protocol":"Medication","Drug name":"Fluoxetine;Sertraline;Citalopram;Venlafaxine;Buproprion;Escitalopram;Duloxetine","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":397,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.9 (2.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":397,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SADQ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.7 (5.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":398,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Taiwanese Depression Questionnaire","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"6.58(7.57)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":399,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.6 (3.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":399,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.1 (4.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":400,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.86 (3.88)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":401,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.24(3.17)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Ankylosing Spondylitis (AS)"},{"S-NO":402,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":403,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.82(7.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":404,"Group name":"Low dose,Black","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"RCDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"54.5 (12.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Overweight"},{"S-NO":404,"Group name":"Low dose,White","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"RCDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"51.3 (11.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Overweight"},{"S-NO":404,"Group name":"High dose,Black","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"RCDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"50.8 (12.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Overweight"},{"S-NO":404,"Group name":"High dose,White","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"RCDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"48.0 (9.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Overweight"},{"S-NO":405,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"15.43 (7.49)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Chronic stroke"},{"S-NO":405,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"PHQ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.17 (3.98)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Chronic stroke"},{"S-NO":406,"Group name":"Strength","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV;ICD-10","Depressive symptom degree":"Mild to moderate","Rating scale":"HAMD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.2(3.6)","Treatment protocol":"Medication(70.9%);Psychotherapy(43.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":406,"Group name":"Aerobic","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV;ICD-10","Depressive symptom degree":"Mild to moderate","Rating scale":"HAMD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.2(3.8)","Treatment protocol":"Medication(67.3%);Psychotherapy(50.9%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":406,"Group name":"Strength","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV;ICD-10","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.0(5.6)","Treatment protocol":"Medication(70.9%);Psychotherapy(43.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":406,"Group name":"Aerobic","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV;ICD-10","Depressive symptom degree":"Mild to moderate","Rating scale":"MADRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.9(5.5)","Treatment protocol":"Medication(67.3%);Psychotherapy(50.9%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":406,"Group name":"Strength","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV;ICD-10","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30.6(8.8)","Treatment protocol":"Medication(70.9%);Psychotherapy(43.6%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":406,"Group name":"Aerobic","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV;ICD-10","Depressive symptom degree":"Mild to moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30.5(6.9)","Treatment protocol":"Medication(67.3%);Psychotherapy(50.9%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":407,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.8(8.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":408,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(19%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":409,"Group name":"Physical activity","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"HAM-D","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication","Drug name":"SSRI(60%);SNRI(30%);NARI(10%)","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":410,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"13.63 (3.62)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":410,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.15 (4.25)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":411,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.5(2.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":412,"Group name":"Supervised aerobic exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.4 (3.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":412,"Group name":"Home-based aerobic exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.3 (4.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":413,"Group name":"Supervised aerobic exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16(4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":413,"Group name":"Home-based aerobic exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17(5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":413,"Group name":"Supervised aerobic exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"30(8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":413,"Group name":"Home-based aerobic exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"31(9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":414,"Group name":"Group-based exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.0 (5.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Ankylosing spondylitis"},{"S-NO":414,"Group name":"Home-based exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.5 (5.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Ankylosing spondylitis"},{"S-NO":415,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"14.13(5.12)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":416,"Group name":"Pulmonary rehabilitation","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"5.9 (4.9\u20137.0) ","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic breathing disorders"},{"S-NO":416,"Group name":"Pulmonary rehabilitation + progressive muscle relaxation","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(95% CI)","Scale scores(values)":"4.9 (3.8\u20135.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Chronic breathing disorders"},{"S-NO":417,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Breast cancer"},{"S-NO":418,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CSDD","Scale scores(statistical indicators)":"mean(SD)(range)","Scale scores(values)":"12.4(4.65)(7-22)","Treatment protocol":"Medication(36%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Alzheimer's disease (AD)"},{"S-NO":419,"Group name":"Exercise","Depressive disorders classification":"Minor depression","Diagnostic criteria":"PHQ-9","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.7 (3.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":419,"Group name":"Exercise","Depressive disorders classification":"Minor depression","Diagnostic criteria":"PHQ-9","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.0 (3.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":420,"Group name":"Clinic-based","Depressive disorders classification":"Major Depression;Dysthymia;Depressive Disorder-Not Otherwise Specified","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Minimal(6.3%);Mild(25.0%);Moderate(43.8%);Severe(25.0%)","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"24.6 (8.7)","Treatment protocol":"Medication(25%);Medication and therapy(31.3%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":420,"Group name":"Home-based","Depressive disorders classification":"Major Depression;Dysthymia;Depressive Disorder-Not Otherwise Specified","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Minimal(12.5%);Mild(6.3%);Moderate(50.0%);Severe(31.2%)","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"26.5(10.0)","Treatment protocol":"Medication(6.3%);Psychotherapy(6.3%);Medication and therapy(18.7%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":421,"Group name":"Exercise","Depressive disorders classification":"Bipolar affective disorder;Depressive episode;Recurrent depressive disorder;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"Bech\u2010Rafaelsen Melancholy Scale","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.6 ( 3.7) (12\u201325)","Treatment protocol":"Medication;Sleep deprivation therapy","Drug name":"Tricyclic and tetracyclic antidepressant;SSRI;Monoaminooxidase inhibitors;Lithium carbonate;Trazodone;SNRI;Noradrenalin re\u2010uptake inhibitors","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":421,"Group name":"Control","Depressive disorders classification":"Bipolar affective disorder;Depressive episode;Recurrent depressive disorder;Persistent affective disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"Bech\u2010Rafaelsen Melancholy Scale","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.7 (4.2) (12\u201326)","Treatment protocol":"Medication;Sleep deprivation therapy","Drug name":"Tricyclic and tetracyclic antidepressant;SSRI;Monoaminooxidase inhibitors;Lithium carbonate;Trazodone;SNRI;Noradrenalin re\u2010uptake inhibitors","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":421,"Group name":"Exercise","Depressive disorders classification":"Bipolar affective disorder;Depressive episode;Recurrent depressive disorder;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"37.6 (12.9) (13\u201352)","Treatment protocol":"Medication;Sleep deprivation therapy","Drug name":"Tricyclic and tetracyclic antidepressant;SSRI;Monoaminooxidase inhibitors;Lithium carbonate;Trazodone;SNRI;Noradrenalin re\u2010uptake inhibitors","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":421,"Group name":"Control","Depressive disorders classification":"Bipolar affective disorder;Depressive episode;Recurrent depressive disorder;Persistent affective disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"39.2 (8.5) (21\u201356)","Treatment protocol":"Medication;Sleep deprivation therapy","Drug name":"Tricyclic and tetracyclic antidepressant;SSRI;Monoaminooxidase inhibitors;Lithium carbonate;Trazodone;SNRI;Noradrenalin re\u2010uptake inhibitors","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":422,"Group name":"High-frequency","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.63 (6.50)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":422,"Group name":"High-frequency + group-based intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.38 (4.31)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":422,"Group name":"Low-frequency ","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.29 (4.31)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":423,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.6(2.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":424,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(SCID-I)","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.5(7.1)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"Anxiety disorder;Social phobia;Panic disorder;Generalized anxiety disorder","Underlying diseases":"NA"},{"S-NO":425,"Group name":"Total","Depressive disorders classification":"Unipolar major depression(partial remission)","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean","Scale scores(values)":"12.4","Treatment protocol":"Medication","Drug name":"SSRI;SNRI;Dopaminergic;Augmented\/combination drug regimen","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":425,"Group name":"Total","Depressive disorders classification":"Unipolar major depression(partial remission)","Diagnostic criteria":"MINI","Depressive symptom degree":"NA","Rating scale":"QIDS","Scale scores(statistical indicators)":"mean","Scale scores(values)":"11.9","Treatment protocol":"Medication","Drug name":"SSRI;SNRI;Dopaminergic;Augmented\/combination drug regimen","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":426,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.2 (4.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Hypertension;Overweight or obese"},{"S-NO":426,"Group name":"Exercise and weight loss","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.0 (4.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Hypertension;Overweight or obese"},{"S-NO":427,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.4(2.8)","Treatment protocol":"Medication(22.7%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Stroke"},{"S-NO":428,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild to moderate","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"20.1(0.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":429,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.64 (3.61)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":429,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.71 (6.40)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":430,"Group name":"Total","Depressive disorders classification":"Major depressive disorder(unipolar, nonpsychotic)","Diagnostic criteria":"DSM-IV(SCID-CV)","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.4(4.9)","Treatment protocol":"Medication","Drug name":"SSRI;Venlafaxine","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":430,"Group name":"Total","Depressive disorders classification":"Major depressive disorder(unipolar, nonpsychotic)","Diagnostic criteria":"DSM-IV(SCID-CV)","Depressive symptom degree":"NA","Rating scale":"IDS-SR30","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"34.8(7.1)","Treatment protocol":"Medication","Drug name":"SSRI;Venlafaxine","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":431,"Group name":"Exercise","Depressive disorders classification":"Depression;Dysthymia;Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.17(2.75)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":432,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.3(4.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":433,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.3(3.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":434,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"7.95(5.66)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":435,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":436,"Group name":"LD\/3","Depressive disorders classification":"Major depressive disorder(first episode;recurrent)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to moderate","Rating scale":"HRSD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.3 (2.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":436,"Group name":"LD\/5","Depressive disorders classification":"Major depressive disorder(first episode;previous single;recurrent)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to moderate","Rating scale":"HRSD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.2 (2.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":436,"Group name":"PHD\/3","Depressive disorders classification":"Major depressive disorder(first episode;previous single;recurrent)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to moderate","Rating scale":"HRSD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.1 (1.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":436,"Group name":"PHD\/5","Depressive disorders classification":"Major depressive disorder(first episode;previous single;recurrent)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to moderate","Rating scale":"HRSD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.1 (2.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":436,"Group name":"Control","Depressive disorders classification":"Major depressive disorder(previous single;recurrent)","Diagnostic criteria":"DSM-IV(SCID)","Depressive symptom degree":"Mild to moderate","Rating scale":"HRSD17","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.5 (2.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":437,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Mood disorders;Anxiety disorders;Adjustment disorders;Personality disorders;Substance-related disorders;Other diagnoses","Underlying diseases":"NA"},{"S-NO":438,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Ankylosing spondylitis (AS)"},{"S-NO":439,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.562(2.782)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Oncological or hematological disease"},{"S-NO":440,"Group name":"Walking","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"6.0 (0.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":440,"Group name":"Resistance\/flexibility","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"5.2 (0.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":441,"Group name":"Total","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.7(3.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Schizophrenia;Bipolar disorder","Underlying diseases":"NA"},{"S-NO":442,"Group name":"High intensity","Depressive disorders classification":"Major depression;Minor depression;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"20.0(4.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":442,"Group name":"Low intensity","Depressive disorders classification":"Major depression;Minor depression;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"22.0(4.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":442,"Group name":"High intensity","Depressive disorders classification":"Major depression;Minor depression;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"18.0(4.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":442,"Group name":"Low intensity","Depressive disorders classification":"Major depression;Minor depression;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"19.5(5.3)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":443,"Group name":"Aerobic exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"18.9(9.33)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":443,"Group name":"Anaerobic exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.36(5.23)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":443,"Group name":"Leisure activities","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.28(7.55)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":444,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":445,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.3(4.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Tension","Underlying diseases":"NA"},{"S-NO":446,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.25 (4.00)","Treatment protocol":"Medication(55%);Psychotherapy(55%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":447,"Group name":"Strength","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean[95% CI]","Scale scores(values)":"6.0 [4.5;7.6]","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":447,"Group name":"All-round functional","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean[95% CI]","Scale scores(values)":"5.6 [4.3;6.8]","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":447,"Group name":"Combination","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean[95% CI]","Scale scores(values)":"6.1 [4.8;7.5]","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":448,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"Depression Status Inventory scale","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"57.785 (0.43)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":449,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"EPDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.40 (4.65)","Treatment protocol":"Medication(NA%);Psychotherapy(NA%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":449,"Group name":"Exercise","Depressive disorders classification":"Postpartum depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"DASS ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"1.80 (1.69)  ","Treatment protocol":"Medication(NA%);Psychotherapy(NA%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":450,"Group name":"Yoga","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Mild","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.77(4.53)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":451,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.3(11.8)","Treatment protocol":"Medication(17%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"HIV"},{"S-NO":451,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.6(6.0)","Treatment protocol":"Medication(17%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"HIV"},{"S-NO":452,"Group name":"Depression","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.6(10.7)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":453,"Group name":"Exercise","Depressive disorders classification":"Mood (affective) disorder","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean","Scale scores(values)":"16.7","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":453,"Group name":"Exercise","Depressive disorders classification":"Mood (affective) disorder","Diagnostic criteria":"ICD-10","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean","Scale scores(values)":"18.2","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":454,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D","Scale scores(statistical indicators)":"mean","Scale scores(values)":"2.74","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Knee osteoarthritis"},{"S-NO":455,"Group name":"Light Plus Aerobics","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.8(7.0)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":455,"Group name":"Aerobics","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.0(5.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":455,"Group name":"Light Plus Stretching","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.4(6.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":456,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"SDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"44.8(8.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":457,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.5 (3.3)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":457,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"Moderate to severe","Rating scale":"Scale for Self assessment of Depression","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.2 (7)","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":458,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"8.9(0.77)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":458,"Group name":"Exercise and medication","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"10.6(0.75)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":459,"Group name":"Depression","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"POMS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"65.31(10.33)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":460,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"11.1(2.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Obesity"},{"S-NO":461,"Group name":"Depressed SAD-PET","Depressive disorders classification":"Winter depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.4(5.2)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":461,"Group name":"Depressed non-SAD-PET","Depressive disorders classification":"Minor depressive disorder;Dysthymia;Major depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HDRS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"19.9(4.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":462,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD;BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":463,"Group name":"Exercise","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD;BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":463,"Group name":"Combination","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HAMD;BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":464,"Group name":"Depression","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"10.7(3.7)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Coronary artery disease"},{"S-NO":465,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"8.8(9.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Spinal cord injury paraplegia"},{"S-NO":466,"Group name":"Exercise","Depressive disorders classification":"Minor depression;Major depression;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.3(1.8)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":466,"Group name":"Exercise","Depressive disorders classification":"Minor depression;Major depression;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"HRSD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"12.3 (0.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":466,"Group name":"Exercise","Depressive disorders classification":"Minor depression;Major depression;Dysthymia","Diagnostic criteria":"DSM-IV","Depressive symptom degree":"NA","Rating scale":"GDS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.9(1.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":467,"Group name":"Depression","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"11.2(3.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Major cardiac event (myocardial infarction,coronary artery bypass surgery, or percutaneous transluminal coronary angioplasty)"},{"S-NO":468,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"17.57 (9.57) ","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Physical disabilities"},{"S-NO":469,"Group name":"Aerobics","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"20.6(13.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Substance abuse"},{"S-NO":469,"Group name":"Circuit training","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"23.9(9.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Substance abuse"},{"S-NO":469,"Group name":"Bodybuilding","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"CES-D ","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"29.5(14.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Substance abuse"},{"S-NO":470,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":471,"Group name":"Aerobic","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"22.91(1.1)","Treatment protocol":"Medication(45%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":471,"Group name":"Aerobic","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"23(1.08)","Treatment protocol":"Medication(41.2%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":471,"Group name":"Low intensity","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"22(1.37)","Treatment protocol":"Medication(11.5%)","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":472,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HAD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"4.6(2.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"Cardiac illness(coronary artery bypass graft patients)"},{"S-NO":473,"Group name":"Aerobic","Depressive disorders classification":"Major depression;Dysthymic disorder;Depressive disorder not otherwise specified","Diagnostic criteria":"DSM-III(SCID)","Depressive symptom degree":"NA","Rating scale":"MADRS;BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(27%);Psychotherapy","Drug name":"TCA","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":473,"Group name":"Nonaerobic","Depressive disorders classification":"Major depression;Dysthymic disorder;Depressive disorder not otherwise specified","Diagnostic criteria":"DSM-III(SCID)","Depressive symptom degree":"NA","Rating scale":"MADRS;BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(30%);Psychotherapy","Drug name":"TCA","Comorbidity(mental disease)":"Anxiety disorder","Underlying diseases":"NA"},{"S-NO":474,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"16.6(3.1)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":475,"Group name":"Exercise","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean(SE)","Scale scores(values)":"7.7(1.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"End-stage renal disease(undergoing maintenance hemodialysis)"},{"S-NO":476,"Group name":"Depression","Depressive disorders classification":"Depression","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"NA","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":477,"Group name":"Total","Depressive disorders classification":"Major depression(single;recurrent)","Diagnostic criteria":"DSM","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication(53%);Psychotherapy","Drug name":"TCA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":478,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI","Scale scores(statistical indicators)":"mean","Scale scores(values)":"15.35","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":479,"Group name":"Younger","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.9(3.5)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":479,"Group name":"Middle-Aged","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.3(2.9)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":479,"Group name":"Older","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"HADS","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"3.3(3.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"Anxiety symptoms","Underlying diseases":"NA"},{"S-NO":480,"Group name":"Hybrid comprehensive telerehabilitation","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"9.8(6.4)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"Heart failure"},{"S-NO":481,"Group name":"Total","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"Moderate","Rating scale":"BDI-II","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"22.52(9.57)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":482,"Group name":"Total","Depressive disorders classification":"Major depressive disorder","Diagnostic criteria":"DSM-IV(MINI)","Depressive symptom degree":"NA","Rating scale":"HAMD","Scale scores(statistical indicators)":"NA","Scale scores(values)":"NA","Treatment protocol":"Medication","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":483,"Group name":"Intervention","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV (SCID I\/II)","Depressive symptom degree":"Moderate or severe","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.45 (5.6)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":483,"Group name":"Active control","Depressive disorders classification":"Major depressive episode","Diagnostic criteria":"DSM-IV (SCID I\/II)","Depressive symptom degree":"Moderate or severe","Rating scale":"HAMD","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"21.84 (5.14)","Treatment protocol":"NA","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"},{"S-NO":484,"Group name":"Intervention","Depressive disorders classification":"Depressive symptoms","Diagnostic criteria":"NA","Depressive symptom degree":"NA","Rating scale":"GDS-15","Scale scores(statistical indicators)":"mean(SD)","Scale scores(values)":"5.4(3.2)","Treatment protocol":"Medication(24%)","Drug name":"NA","Comorbidity(mental disease)":"NA","Underlying diseases":"NA"}]

const Dicolumns = [
  {
    title: 'S-NO',
    key: 'S-NO',
  },
  {
    title: 'Group name',
    key: 'Group name',
  },
  {
    title: 'Depressive disorders classification',
    key: 'Depressive disorders classification',
  },
  {
    title: 'Diagnostic criteria',
    key: 'Diagnostic criteria',
  },
  {
    title: 'Depressive symptom degree',
    key: 'Depressive symptom degree',
  },
  {
    title: 'Rating scale',
    key: 'Rating scale',
  },
  {
    title: 'Scale scores(statistical indicators)',
    key: 'Scale scores(statistical indicators)',
  },
  {
    title: 'Scale scores (values)',
    key: 'Scale scores (values)',
  },
  {
    title: 'Treatment protocol',
    key: 'Treatment protocol',
  },
  {
    title: 'Drug name',
    key: 'Drug name',
  },
  {
    title: 'Comorbidity (mental disease)',
    key: 'Comorbidity (mental disease)',
  },
  {
    title: 'Underlying diseases',
    key: 'Underlying diseases',
  },
];





export default defineComponent({
  setup () {
    return {
      di_data: DiData,
      di_columns: Dicolumns,
      pagination: {
        pageSize: 10
      }
    }
  }
})

</script>

<template>
<n-space vertical size="large" class="container">

<n-layout-content style="display: flex; justify-content: center; align-items: center; padding: 24px; position: relative;width: 90%;margin-left: auto; margin-right: auto;">
  <n-gradient-text :size="60" type="info">
    Database
  </n-gradient-text>

  <h2 style="text-align: center;">Depression information</h2>

  <!-- <h2 style="text-align: center;">Physical fitness assessment</h2> -->
  <!-- <h2 style="text-align: center;">Exercise risk assessment</h2> -->
  <!-- <h2 style="text-align: center;">Physical activity intervention protocol</h2> -->
  <!-- <h2 style="text-align: center;">Adverse events evaluation</h2> -->
  <!-- <h2 style="text-align: center;">Physical activity effect evaluation</h2> -->

  <n-card>
    <n-data-table
    :columns="di_columns"
    :data="di_data"
    max-height="360px"
    :pagination="pagination"
    />
  </n-card>

  <n-card>
    <Bi_table></Bi_table>
  </n-card>
</n-layout-content>
</n-space>
</template>          

<!-- scoped关键词是限定样式的作用范围 -->
<style scoped>
.n-gradient-text {
  font-size: 24px; /* 增大字号 */
  font-weight: bold; /* 加粗 */
  text-align: center; /* 居中对齐 */
  margin-bottom: 20px; /* 与下方元素的间距 */
  background: linear-gradient(90deg, #D5E3D4, #56ab2f); /* 浅绿色渐变色 */
  -webkit-background-clip: text;
  -webkit-text-fill-color: transparent; /* 渐变文字颜色 */
}
</style>
